# Boeing timeline entity: /record/boeing.md id: ent_boeing Boeing's timeline holds 605 claims from 2006 to 2026: 2 people, 593 money & deals, 10 other. 10 are undated. The latest took effect on October 20, 2026. Kinds: People 2 (/timelines/boeing.md?kind=people) · Money & deals 593 (/timelines/boeing.md?kind=money) · Products 0 (/timelines/boeing.md?kind=products) · Models 0 (/timelines/boeing.md?kind=models) · Other 10 (/timelines/boeing.md?kind=other) Format: date | kind | predicate | value | status | claim. ## 2006 - 2006-12-31 to 2007-12-31 | money | cash_and_equivalents | 6,118,000,000 United States dollar | superseded | [clm_273F52A3E387](/claim/clm_273F52A3E387.md) - 2006-12-31 to 2007-12-31 | money | total_equity | 4,792,000,000 United States dollar | superseded | [clm_B72B2342E998](/claim/clm_B72B2342E998.md) ## 2007 - 2007-12-31 to 2008-06-30 | money | cash_and_equivalents | 7,042,000,000 United States dollar | superseded | [clm_5310782475D2](/claim/clm_5310782475D2.md) - 2007-12-31 to 2008-12-31 | money | net_income | 4,074,000,000 United States dollar | superseded | [clm_D023A4E5DEE5](/claim/clm_D023A4E5DEE5.md) - 2007-12-31 to 2008-12-31 | money | operating_income | 5,830,000,000 United States dollar | superseded | [clm_ACA555B0C8EB](/claim/clm_ACA555B0C8EB.md) - 2007-12-31 to 2008-12-31 | money | research_and_development | 3,850,000,000 United States dollar | superseded | [clm_98EFE3AFB7CD](/claim/clm_98EFE3AFB7CD.md) - 2007-12-31 to 2008-12-31 | money | revenue | 66,387,000,000 United States dollar | superseded | [clm_B62AAEB17FAE](/claim/clm_B62AAEB17FAE.md) - 2007-12-31 to 2008-12-31 | money | total_equity | 9,078,000,000 United States dollar | superseded | [clm_F8EAE72D8674](/claim/clm_F8EAE72D8674.md) ## 2008 - 2008-06-30 to 2008-09-30 | money | cash_and_equivalents | 5,619,000,000 United States dollar | superseded | [clm_8DEE131D9828](/claim/clm_8DEE131D9828.md) - 2008-06-30 to 2008-09-30 | money | quarterly_net_income | 852,000,000 United States dollar | superseded | [clm_5CF0600AEADB](/claim/clm_5CF0600AEADB.md) - 2008-06-30 to 2008-09-30 | money | quarterly_operating_income | 1,247,000,000 United States dollar | superseded | [clm_A8EAF8094B8B](/claim/clm_A8EAF8094B8B.md) - 2008-06-30 to 2008-09-30 | money | quarterly_research_and_development | 1,005,000,000 United States dollar | superseded | [clm_B16A5E0080F3](/claim/clm_B16A5E0080F3.md) - 2008-06-30 to 2008-09-30 | money | quarterly_revenue | 16,962,000,000 United States dollar | superseded | [clm_5E52AF5E2D3E](/claim/clm_5E52AF5E2D3E.md) - 2008-09-30 to 2008-12-31 | money | cash_and_equivalents | 4,186,000,000 United States dollar | superseded | [clm_7860E1AB3827](/claim/clm_7860E1AB3827.md) - 2008-09-30 to 2009-03-31 | money | quarterly_net_income | 695,000,000 United States dollar | superseded | [clm_945484D8CEFB](/claim/clm_945484D8CEFB.md) - 2008-09-30 to 2009-03-31 | money | quarterly_operating_income | 1,147,000,000 United States dollar | superseded | [clm_2547863C7159](/claim/clm_2547863C7159.md) - 2008-09-30 to 2009-03-31 | money | quarterly_research_and_development | 937,000,000 United States dollar | superseded | [clm_76EC0CAFCBCB](/claim/clm_76EC0CAFCBCB.md) - 2008-09-30 to 2009-03-31 | money | quarterly_revenue | 15,293,000,000 United States dollar | superseded | [clm_94C7FB82B75E](/claim/clm_94C7FB82B75E.md) - 2008-12-31 to 2009-03-31 | money | cash_and_equivalents | 3,268,000,000 United States dollar | superseded | [clm_8D6764443799](/claim/clm_8D6764443799.md) - 2008-12-31 to 2009-12-31 | money | net_income | 2,672,000,000 United States dollar | superseded | [clm_1F8593DFB17D](/claim/clm_1F8593DFB17D.md) - 2008-12-31 to 2009-12-31 | money | operating_income | 3,950,000,000 United States dollar | superseded | [clm_1FD9A546AD44](/claim/clm_1FD9A546AD44.md) - 2008-12-31 to 2009-12-31 | money | research_and_development | 3,768,000,000 United States dollar | superseded | [clm_15F16C94CCD0](/claim/clm_15F16C94CCD0.md) - 2008-12-31 to 2009-12-31 | money | revenue | 60,909,000,000 United States dollar | superseded | [clm_D8FFEE10EA44](/claim/clm_D8FFEE10EA44.md) - 2008-12-31 to 2009-06-30 | money | total_assets | 53,779,000,000 United States dollar | superseded | [clm_5AB5C6201569](/claim/clm_5AB5C6201569.md) - 2008-12-31 to 2009-01-02 | money | total_equity | -1,294,000,000 United States dollar | superseded | [clm_FDC7189E8BD1](/claim/clm_FDC7189E8BD1.md) ## 2009 - 2009-01-02 to 2009-03-31 | money | total_equity | -1,142,000,000 United States dollar | superseded | [clm_147D9289D080](/claim/clm_147D9289D080.md) - 2009-03-31 to 2009-06-30 | money | cash_and_equivalents | 4,237,000,000 United States dollar | superseded | [clm_39E0A19011C8](/claim/clm_39E0A19011C8.md) - 2009-03-31 to 2009-06-30 | money | quarterly_net_income | 610,000,000 United States dollar | superseded | [clm_11CC080B9251](/claim/clm_11CC080B9251.md) - 2009-03-31 to 2009-06-30 | money | quarterly_operating_income | 1,025,000,000 United States dollar | superseded | [clm_5348DEAFCBF8](/claim/clm_5348DEAFCBF8.md) - 2009-03-31 to 2009-06-30 | money | quarterly_research_and_development | 970,000,000 United States dollar | superseded | [clm_220B94C08BFD](/claim/clm_220B94C08BFD.md) - 2009-03-31 to 2009-06-30 | money | quarterly_revenue | 16,502,000,000 United States dollar | superseded | [clm_D7E8DBE86A84](/claim/clm_D7E8DBE86A84.md) - 2009-03-31 to 2009-06-30 | money | total_equity | -509,000,000 United States dollar | superseded | [clm_1BBB44BAE2F5](/claim/clm_1BBB44BAE2F5.md) - 2009-06-30 to 2009-09-30 | money | cash_and_equivalents | 4,599,000,000 United States dollar | superseded | [clm_5A748802F32B](/claim/clm_5A748802F32B.md) - 2009-06-30 to 2009-09-30 | money | quarterly_net_income | 998,000,000 United States dollar | superseded | [clm_6193512BA7E2](/claim/clm_6193512BA7E2.md) - 2009-06-30 to 2009-09-30 | money | quarterly_operating_income | 1,529,000,000 United States dollar | superseded | [clm_8812683516D6](/claim/clm_8812683516D6.md) - 2009-06-30 to 2009-09-30 | money | quarterly_research_and_development | 960,000,000 United States dollar | superseded | [clm_353ED639C70F](/claim/clm_353ED639C70F.md) - 2009-06-30 to 2009-09-30 | money | quarterly_revenue | 17,154,000,000 United States dollar | superseded | [clm_A2F04AA06E22](/claim/clm_A2F04AA06E22.md) - 2009-06-30 to 2009-10-16 | money | shares_outstanding | 726,432,299 shares | superseded | [clm_C51E49449630](/claim/clm_C51E49449630.md) - 2009-06-30 to 2009-09-30 | money | total_assets | 57,712,000,000 United States dollar | superseded | [clm_0601DF273737](/claim/clm_0601DF273737.md) - 2009-06-30 to 2009-09-30 | money | total_equity | 180,000,000 United States dollar | superseded | [clm_129CC890CD73](/claim/clm_129CC890CD73.md) - 2009-09-30 to 2009-12-31 | money | cash_and_equivalents | 6,095,000,000 United States dollar | superseded | [clm_332CB6CDA945](/claim/clm_332CB6CDA945.md) - 2009-09-30 to 2010-03-31 | money | quarterly_net_income | -1,564,000,000 United States dollar | superseded | [clm_A8F423BF1F76](/claim/clm_A8F423BF1F76.md) - 2009-09-30 to 2010-03-31 | money | quarterly_operating_income | -2,151,000,000 United States dollar | superseded | [clm_4982C584A55A](/claim/clm_4982C584A55A.md) - 2009-09-30 to 2010-03-31 | money | quarterly_research_and_development | 3,574,000,000 United States dollar | superseded | [clm_FB2B3548F0E0](/claim/clm_FB2B3548F0E0.md) - 2009-09-30 to 2010-03-31 | money | quarterly_revenue | 16,688,000,000 United States dollar | superseded | [clm_7F4EF9234908](/claim/clm_7F4EF9234908.md) - 2009-09-30 to 2009-12-31 | money | total_assets | 58,667,000,000 United States dollar | superseded | [clm_CF448BD12FEF](/claim/clm_CF448BD12FEF.md) - 2009-09-30 to 2009-12-31 | money | total_equity | -1,028,000,000 United States dollar | superseded | [clm_65309330A8C4](/claim/clm_65309330A8C4.md) - 2009-10-16 to 2010-02-01 | money | shares_outstanding | 726,599,064 shares | superseded | [clm_B20E1AF76898](/claim/clm_B20E1AF76898.md) - 2009-12-31 to 2010-03-31 | money | cash_and_equivalents | 9,215,000,000 United States dollar | superseded | [clm_3A5F3383D334](/claim/clm_3A5F3383D334.md) - 2009-12-31 to 2010-12-31 | money | net_income | 1,312,000,000 United States dollar | superseded | [clm_E30CF78F5FA4](/claim/clm_E30CF78F5FA4.md) - 2009-12-31 to 2010-12-31 | money | operating_income | 2,096,000,000 United States dollar | superseded | [clm_62FCC99A26A2](/claim/clm_62FCC99A26A2.md) - 2009-12-31 to 2010-12-31 | money | research_and_development | 6,506,000,000 United States dollar | superseded | [clm_9F66575A0CB1](/claim/clm_9F66575A0CB1.md) - 2009-12-31 to 2010-12-31 | money | revenue | 68,281,000,000 United States dollar | superseded | [clm_89B0AF429342](/claim/clm_89B0AF429342.md) - 2009-12-31 to 2010-03-31 | money | total_assets | 62,053,000,000 United States dollar | superseded | [clm_9B7480FD6CEA](/claim/clm_9B7480FD6CEA.md) - 2009-12-31 to 2010-03-31 | money | total_equity | 2,128,000,000 United States dollar | superseded | [clm_5D02FB4B0DC5](/claim/clm_5D02FB4B0DC5.md) ## 2010 - 2010-02-01 to 2010-04-16 | money | shares_outstanding | 756,976,242 shares | superseded | [clm_C74F0866D1B7](/claim/clm_C74F0866D1B7.md) - 2010-03-31 to 2010-06-30 | money | cash_and_equivalents | 4,517,000,000 United States dollar | superseded | [clm_908A08F5DDF6](/claim/clm_908A08F5DDF6.md) - 2010-03-31 to 2010-06-30 | money | quarterly_net_income | 519,000,000 United States dollar | superseded | [clm_86B3D1AE3269](/claim/clm_86B3D1AE3269.md) - 2010-03-31 to 2010-06-30 | money | quarterly_operating_income | 1,174,000,000 United States dollar | superseded | [clm_0307F685AA64](/claim/clm_0307F685AA64.md) - 2010-03-31 to 2010-06-30 | money | quarterly_research_and_development | 1,000,000,000 United States dollar | superseded | [clm_9C812F3BB043](/claim/clm_9C812F3BB043.md) - 2010-03-31 to 2010-06-30 | money | quarterly_revenue | 15,216,000,000 United States dollar | superseded | [clm_FBBDD63519F8](/claim/clm_FBBDD63519F8.md) - 2010-03-31 to 2010-06-30 | money | total_assets | 62,970,000,000 United States dollar | superseded | [clm_A098EC1EE711](/claim/clm_A098EC1EE711.md) - 2010-03-31 to 2010-06-30 | money | total_equity | 2,942,000,000 United States dollar | superseded | [clm_358343694C44](/claim/clm_358343694C44.md) - 2010-04-16 to 2010-07-21 | money | shares_outstanding | 759,036,516 shares | superseded | [clm_4FA1B207AA39](/claim/clm_4FA1B207AA39.md) - 2010-06-30 to 2010-09-30 | money | cash_and_equivalents | 4,468,000,000 United States dollar | superseded | [clm_85E90040F978](/claim/clm_85E90040F978.md) - 2010-06-30 to 2010-09-30 | money | quarterly_net_income | 787,000,000 United States dollar | superseded | [clm_9AD53C11207E](/claim/clm_9AD53C11207E.md) - 2010-06-30 to 2010-09-30 | money | quarterly_operating_income | 1,307,000,000 United States dollar | superseded | [clm_6C3736D92A14](/claim/clm_6C3736D92A14.md) - 2010-06-30 to 2010-09-30 | money | quarterly_research_and_development | 1,001,000,000 United States dollar | superseded | [clm_B00176F80985](/claim/clm_B00176F80985.md) - 2010-06-30 to 2010-09-30 | money | quarterly_revenue | 15,573,000,000 United States dollar | superseded | [clm_E0B9114B3A67](/claim/clm_E0B9114B3A67.md) - 2010-06-30 to 2010-09-30 | money | total_assets | 63,755,000,000 United States dollar | superseded | [clm_2F7DEFFC544F](/claim/clm_2F7DEFFC544F.md) - 2010-06-30 to 2010-09-30 | money | total_equity | 3,077,000,000 United States dollar | superseded | [clm_348F971F18CE](/claim/clm_348F971F18CE.md) - 2010-07-21 to 2010-10-13 | money | shares_outstanding | 731,681,424 shares | superseded | [clm_A0762F829C28](/claim/clm_A0762F829C28.md) - 2010-09-30 to 2010-12-31 | money | cash_and_equivalents | 2,864,000,000 United States dollar | superseded | [clm_270B6499AD0C](/claim/clm_270B6499AD0C.md) - 2010-09-30 to 2011-03-31 | money | quarterly_net_income | 837,000,000 United States dollar | superseded | [clm_32034B00382A](/claim/clm_32034B00382A.md) - 2010-09-30 to 2011-03-31 | money | quarterly_operating_income | 1,387,000,000 United States dollar | superseded | [clm_2FE8541567DE](/claim/clm_2FE8541567DE.md) - 2010-09-30 to 2011-03-31 | money | quarterly_research_and_development | 986,000,000 United States dollar | superseded | [clm_A35EE0797EA5](/claim/clm_A35EE0797EA5.md) - 2010-09-30 to 2011-03-31 | money | quarterly_revenue | 16,967,000,000 United States dollar | superseded | [clm_B73008E6D095](/claim/clm_B73008E6D095.md) - 2010-09-30 to 2010-12-31 | money | total_assets | 65,222,000,000 United States dollar | superseded | [clm_7DCF2F9CD779](/claim/clm_7DCF2F9CD779.md) - 2010-09-30 to 2010-12-31 | money | total_equity | 4,454,000,000 United States dollar | superseded | [clm_7E42C67820D9](/claim/clm_7E42C67820D9.md) - 2010-10-13 to 2011-02-01 | money | shares_outstanding | 733,580,492 shares | superseded | [clm_8AE8240568A9](/claim/clm_8AE8240568A9.md) - 2010-12-31 to 2011-03-31 | money | cash_and_equivalents | 5,359,000,000 United States dollar | superseded | [clm_1A2F9853712E](/claim/clm_1A2F9853712E.md) - 2010-12-31 to 2011-12-31 | money | net_income | 3,307,000,000 United States dollar | superseded | [clm_8E77B58F0840](/claim/clm_8E77B58F0840.md) - 2010-12-31 to 2011-12-31 | money | operating_income | 4,971,000,000 United States dollar | superseded | [clm_09F44A9EB931](/claim/clm_09F44A9EB931.md) - 2010-12-31 to 2011-12-31 | money | research_and_development | 4,121,000,000 United States dollar | superseded | [clm_F4E55CDE16AC](/claim/clm_F4E55CDE16AC.md) - 2010-12-31 to 2011-12-31 | money | revenue | 64,306,000,000 United States dollar | superseded | [clm_8B43CE99C413](/claim/clm_8B43CE99C413.md) - 2010-12-31 to 2011-03-31 | money | total_assets | 68,565,000,000 United States dollar | superseded | [clm_A8F8BD3781DA](/claim/clm_A8F8BD3781DA.md) - 2010-12-31 to 2011-03-31 | money | total_equity | 2,766,000,000 United States dollar | superseded | [clm_5DE778699C52](/claim/clm_5DE778699C52.md) ## 2011 - 2011-02-01 to 2011-04-20 | money | shares_outstanding | 736,295,504 shares | superseded | [clm_6795BB3F047A](/claim/clm_6795BB3F047A.md) - 2011-03-31 to 2011-06-30 | money | cash_and_equivalents | 5,670,000,000 United States dollar | superseded | [clm_8803ADB73A34](/claim/clm_8803ADB73A34.md) - 2011-03-31 to 2011-06-30 | money | quarterly_net_income | 586,000,000 United States dollar | superseded | [clm_522E421F4FA4](/claim/clm_522E421F4FA4.md) - 2011-03-31 to 2011-06-30 | money | quarterly_operating_income | 1,000,000,000 United States dollar | superseded | [clm_CCDA362966A0](/claim/clm_CCDA362966A0.md) - 2011-03-31 to 2011-06-30 | money | quarterly_research_and_development | 1,057,000,000 United States dollar | superseded | [clm_39A899F11B5A](/claim/clm_39A899F11B5A.md) - 2011-03-31 to 2011-06-30 | money | quarterly_revenue | 14,910,000,000 United States dollar | superseded | [clm_2FC49C92DD37](/claim/clm_2FC49C92DD37.md) - 2011-03-31 to 2011-06-30 | money | total_assets | 68,760,000,000 United States dollar | superseded | [clm_2200C459EFCC](/claim/clm_2200C459EFCC.md) - 2011-03-31 to 2011-06-30 | money | total_equity | 3,912,000,000 United States dollar | superseded | [clm_E9CA6A13D3AC](/claim/clm_E9CA6A13D3AC.md) - 2011-04-20 to 2011-07-20 | money | shares_outstanding | 738,274,839 shares | superseded | [clm_905D363A152D](/claim/clm_905D363A152D.md) - 2011-06-30 to 2011-09-30 | money | cash_and_equivalents | 5,050,000,000 United States dollar | superseded | [clm_1F347EF89260](/claim/clm_1F347EF89260.md) - 2011-06-30 to 2011-09-30 | money | quarterly_net_income | 941,000,000 United States dollar | superseded | [clm_06CE0A87C085](/claim/clm_06CE0A87C085.md) - 2011-06-30 to 2011-09-30 | money | quarterly_operating_income | 1,534,000,000 United States dollar | superseded | [clm_8538F05AE12D](/claim/clm_8538F05AE12D.md) - 2011-06-30 to 2011-09-30 | money | quarterly_research_and_development | 1,047,000,000 United States dollar | superseded | [clm_FC9E7441B42C](/claim/clm_FC9E7441B42C.md) - 2011-06-30 to 2011-09-30 | money | quarterly_revenue | 16,543,000,000 United States dollar | superseded | [clm_02C35C71107F](/claim/clm_02C35C71107F.md) - 2011-06-30 to 2011-09-30 | money | total_assets | 72,119,000,000 United States dollar | superseded | [clm_DCB0147C7687](/claim/clm_DCB0147C7687.md) - 2011-06-30 to 2011-09-30 | money | total_equity | 4,733,000,000 United States dollar | superseded | [clm_2465DA041C4E](/claim/clm_2465DA041C4E.md) - 2011-07-20 to 2011-10-19 | money | shares_outstanding | 741,091,503 shares | superseded | [clm_0870E877A5C2](/claim/clm_0870E877A5C2.md) - 2011-09-30 to 2011-12-31 | money | cash_and_equivalents | 5,954,000,000 United States dollar | superseded | [clm_A4F5B0327163](/claim/clm_A4F5B0327163.md) - 2011-09-30 to 2012-03-31 | money | quarterly_net_income | 1,098,000,000 United States dollar | superseded | [clm_86DC2F211076](/claim/clm_86DC2F211076.md) - 2011-09-30 to 2012-03-31 | money | quarterly_operating_income | 1,714,000,000 United States dollar | superseded | [clm_8B42349C6769](/claim/clm_8B42349C6769.md) - 2011-09-30 to 2012-03-31 | money | quarterly_research_and_development | 901,000,000 United States dollar | superseded | [clm_C3D410104020](/claim/clm_C3D410104020.md) - 2011-09-30 to 2012-03-31 | money | quarterly_revenue | 17,727,000,000 United States dollar | superseded | [clm_1C63A10B7D3C](/claim/clm_1C63A10B7D3C.md) - 2011-09-30 to 2011-12-31 | money | total_assets | 74,163,000,000 United States dollar | superseded | [clm_07AF7133397F](/claim/clm_07AF7133397F.md) - 2011-09-30 to 2011-12-31 | money | total_equity | 5,967,000,000 United States dollar | superseded | [clm_4058F7345CD6](/claim/clm_4058F7345CD6.md) - 2011-10-19 to 2012-02-01 | money | shares_outstanding | 743,234,446 shares | superseded | [clm_2154268FAFF6](/claim/clm_2154268FAFF6.md) - 2011-12-31 to 2012-03-31 | money | cash_and_equivalents | 10,049,000,000 United States dollar | superseded | [clm_246EC70A9AAC](/claim/clm_246EC70A9AAC.md) - 2011-12-31 to 2012-12-31 | money | net_income | 4,018,000,000 United States dollar | superseded | [clm_20305D3A99B2](/claim/clm_20305D3A99B2.md) - 2011-12-31 to 2012-12-31 | money | operating_income | 5,844,000,000 United States dollar | superseded | [clm_3498185345F2](/claim/clm_3498185345F2.md) - 2011-12-31 to 2012-12-31 | money | research_and_development | 3,918,000,000 United States dollar | superseded | [clm_FC2CF60BB379](/claim/clm_FC2CF60BB379.md) - 2011-12-31 to 2012-12-31 | money | revenue | 68,735,000,000 United States dollar | superseded | [clm_A9CA3E62BD19](/claim/clm_A9CA3E62BD19.md) - 2011-12-31 to 2012-03-31 | money | total_assets | 79,986,000,000 United States dollar | superseded | [clm_C48D0D7E160C](/claim/clm_C48D0D7E160C.md) - 2011-12-31 to 2012-03-31 | money | total_equity | 3,515,000,000 United States dollar | superseded | [clm_5DF12BF249FE](/claim/clm_5DF12BF249FE.md) ## 2012 - 2012-02-01 to 2012-04-18 | money | shares_outstanding | 745,720,763 shares | superseded | [clm_CD3832FC8BAC](/claim/clm_CD3832FC8BAC.md) - 2012-03-31 to 2012-06-30 | money | cash_and_equivalents | 6,718,000,000 United States dollar | superseded | [clm_7B6E38228731](/claim/clm_7B6E38228731.md) - 2012-03-31 to 2012-06-30 | money | quarterly_net_income | 923,000,000 United States dollar | superseded | [clm_F2DC166B57FF](/claim/clm_F2DC166B57FF.md) - 2012-03-31 to 2012-06-30 | money | quarterly_operating_income | 1,570,000,000 United States dollar | superseded | [clm_2C3F97A64E95](/claim/clm_2C3F97A64E95.md) - 2012-03-31 to 2012-06-30 | money | quarterly_research_and_development | 835,000,000 United States dollar | superseded | [clm_6FEF74EF0727](/claim/clm_6FEF74EF0727.md) - 2012-03-31 to 2012-06-30 | money | quarterly_revenue | 19,383,000,000 United States dollar | superseded | [clm_A63FB3597A7D](/claim/clm_A63FB3597A7D.md) - 2012-03-31 to 2012-06-30 | money | total_assets | 80,205,000,000 United States dollar | superseded | [clm_649A0BCE817E](/claim/clm_649A0BCE817E.md) - 2012-03-31 to 2012-06-30 | money | total_equity | 5,027,000,000 United States dollar | superseded | [clm_965C3B36FF68](/claim/clm_965C3B36FF68.md) - 2012-04-18 to 2012-07-18 | money | shares_outstanding | 749,049,454 shares | superseded | [clm_BCA6D3107F6F](/claim/clm_BCA6D3107F6F.md) - 2012-06-30 to 2012-09-30 | money | cash_and_equivalents | 6,305,000,000 United States dollar | superseded | [clm_AABBEDDBA499](/claim/clm_AABBEDDBA499.md) - 2012-06-30 to 2012-09-30 | money | quarterly_net_income | 967,000,000 United States dollar | superseded | [clm_5C5731B7A50A](/claim/clm_5C5731B7A50A.md) - 2012-06-30 to 2012-09-30 | money | quarterly_operating_income | 1,548,000,000 United States dollar | superseded | [clm_96430584D3CF](/claim/clm_96430584D3CF.md) - 2012-06-30 to 2012-09-30 | money | quarterly_research_and_development | 857,000,000 United States dollar | superseded | [clm_005D6B08078A](/claim/clm_005D6B08078A.md) - 2012-06-30 to 2012-09-30 | money | quarterly_revenue | 20,005,000,000 United States dollar | superseded | [clm_3A353A3269DE](/claim/clm_3A353A3269DE.md) - 2012-06-30 to 2012-09-30 | money | total_assets | 81,595,000,000 United States dollar | superseded | [clm_AE469E04AEDF](/claim/clm_AE469E04AEDF.md) - 2012-06-30 to 2012-09-30 | money | total_equity | 5,804,000,000 United States dollar | superseded | [clm_D340A3A95950](/claim/clm_D340A3A95950.md) - 2012-07-18 to 2012-10-17 | money | shares_outstanding | 751,797,604 shares | superseded | [clm_AF155DB4B2BB](/claim/clm_AF155DB4B2BB.md) - 2012-09-30 to 2012-12-31 | money | cash_and_equivalents | 6,582,000,000 United States dollar | superseded | [clm_D1CB6B717DB4](/claim/clm_D1CB6B717DB4.md) - 2012-09-30 to 2013-03-31 | money | quarterly_net_income | 1,032,000,000 United States dollar | superseded | [clm_18C2ADF8B2F6](/claim/clm_18C2ADF8B2F6.md) - 2012-09-30 to 2013-03-31 | money | quarterly_operating_income | 1,564,000,000 United States dollar | superseded | [clm_5268E09A1B56](/claim/clm_5268E09A1B56.md) - 2012-09-30 to 2013-03-31 | money | quarterly_research_and_development | 853,000,000 United States dollar | superseded | [clm_1E3822217E53](/claim/clm_1E3822217E53.md) - 2012-09-30 to 2013-03-31 | money | quarterly_revenue | 20,008,000,000 United States dollar | superseded | [clm_3AB53477E710](/claim/clm_3AB53477E710.md) - 2012-09-30 to 2012-12-31 | money | total_assets | 83,654,000,000 United States dollar | superseded | [clm_3BF4D7312DA2](/claim/clm_3BF4D7312DA2.md) - 2012-09-30 to 2012-12-31 | money | total_equity | 7,588,000,000 United States dollar | superseded | [clm_FD7CFD111123](/claim/clm_FD7CFD111123.md) - 2012-10-17 to 2013-02-01 | money | shares_outstanding | 754,076,883 shares | superseded | [clm_A60F186D5CA5](/claim/clm_A60F186D5CA5.md) - 2012-12-31 to 2013-03-31 | money | cash_and_equivalents | 10,341,000,000 United States dollar | superseded | [clm_E617FACE6E79](/claim/clm_E617FACE6E79.md) - 2012-12-31 to 2013-12-31 | money | net_income | 3,900,000,000 United States dollar | superseded | [clm_F08599B6643D](/claim/clm_F08599B6643D.md) - 2012-12-31 to 2013-12-31 | money | operating_income | 6,311,000,000 United States dollar | superseded | [clm_54938791C480](/claim/clm_54938791C480.md) - 2012-12-31 to 2013-12-31 | money | research_and_development | 3,298,000,000 United States dollar | superseded | [clm_21369B3D94C4](/claim/clm_21369B3D94C4.md) - 2012-12-31 to 2013-12-31 | money | revenue | 81,698,000,000 United States dollar | superseded | [clm_E07F4DD8CD12](/claim/clm_E07F4DD8CD12.md) - 2012-12-31 to 2013-03-31 | money | total_assets | 88,896,000,000 United States dollar | superseded | [clm_DCA3E0B562DA](/claim/clm_DCA3E0B562DA.md) - 2012-12-31 to 2013-03-31 | money | total_equity | 5,867,000,000 United States dollar | superseded | [clm_08850FF110B1](/claim/clm_08850FF110B1.md) ## 2013 - 2013-02-01 to 2013-04-17 | money | shares_outstanding | 756,165,531 shares | superseded | [clm_665BAA171BDF](/claim/clm_665BAA171BDF.md) - 2013-03-31 to 2013-06-30 | money | cash_and_equivalents | 8,335,000,000 United States dollar | superseded | [clm_CB6805E79EFD](/claim/clm_CB6805E79EFD.md) - 2013-03-31 to 2013-06-30 | money | quarterly_net_income | 1,106,000,000 United States dollar | superseded | [clm_33D7B469CE11](/claim/clm_33D7B469CE11.md) - 2013-03-31 to 2013-06-30 | money | quarterly_operating_income | 1,528,000,000 United States dollar | superseded | [clm_6AA50CD7EDCE](/claim/clm_6AA50CD7EDCE.md) - 2013-03-31 to 2013-06-30 | money | quarterly_research_and_development | 705,000,000 United States dollar | superseded | [clm_157CE26557B2](/claim/clm_157CE26557B2.md) - 2013-03-31 to 2013-06-30 | money | quarterly_revenue | 18,893,000,000 United States dollar | superseded | [clm_6D653DF487A4](/claim/clm_6D653DF487A4.md) - 2013-03-31 to 2013-06-30 | money | total_assets | 90,447,000,000 United States dollar | superseded | [clm_E826A892F492](/claim/clm_E826A892F492.md) - 2013-03-31 to 2013-06-30 | money | total_equity | 7,462,000,000 United States dollar | superseded | [clm_EA5E41F1ED6B](/claim/clm_EA5E41F1ED6B.md) - 2013-04-17 to 2013-07-17 | money | shares_outstanding | 758,681,225 shares | superseded | [clm_35C49FAADF38](/claim/clm_35C49FAADF38.md) - 2013-06-30 to 2013-09-30 | money | cash_and_equivalents | 8,694,000,000 United States dollar | superseded | [clm_23A1C31CAEA0](/claim/clm_23A1C31CAEA0.md) - 2013-06-30 to 2013-09-30 | money | quarterly_net_income | 1,088,000,000 United States dollar | superseded | [clm_D545E936498E](/claim/clm_D545E936498E.md) - 2013-06-30 to 2013-09-30 | money | quarterly_operating_income | 1,716,000,000 United States dollar | superseded | [clm_92715A20E667](/claim/clm_92715A20E667.md) - 2013-06-30 to 2013-09-30 | money | quarterly_research_and_development | 763,000,000 United States dollar | superseded | [clm_81D90C98E5D1](/claim/clm_81D90C98E5D1.md) - 2013-06-30 to 2013-09-30 | money | quarterly_revenue | 21,815,000,000 United States dollar | superseded | [clm_EE8CE83587D0](/claim/clm_EE8CE83587D0.md) - 2013-06-30 to 2013-09-30 | money | total_assets | 92,091,000,000 United States dollar | superseded | [clm_906BB8EA4F39](/claim/clm_906BB8EA4F39.md) - 2013-06-30 to 2013-09-30 | money | total_equity | 7,526,000,000 United States dollar | superseded | [clm_13C6A228FD4A](/claim/clm_13C6A228FD4A.md) - 2013-07-17 to 2013-10-16 | money | shares_outstanding | 754,444,329 shares | superseded | [clm_21260A46C44D](/claim/clm_21260A46C44D.md) - 2013-09-30 to 2013-12-31 | money | cash_and_equivalents | 10,041,000,000 United States dollar | superseded | [clm_1EDF405558AD](/claim/clm_1EDF405558AD.md) - 2013-09-30 to 2014-03-31 | money | quarterly_net_income | 1,158,000,000 United States dollar | superseded | [clm_1787D1CEAB26](/claim/clm_1787D1CEAB26.md) - 2013-09-30 to 2014-03-31 | money | quarterly_operating_income | 1,803,000,000 United States dollar | superseded | [clm_002A27D8E43E](/claim/clm_002A27D8E43E.md) - 2013-09-30 to 2014-03-31 | money | quarterly_research_and_development | 755,000,000 United States dollar | superseded | [clm_29456DE9D0FD](/claim/clm_29456DE9D0FD.md) - 2013-09-30 to 2014-03-31 | money | quarterly_revenue | 22,130,000,000 United States dollar | superseded | [clm_213CD4B02A90](/claim/clm_213CD4B02A90.md) - 2013-09-30 to 2013-12-31 | money | total_assets | 94,633,000,000 United States dollar | superseded | [clm_5C5486B86DAF](/claim/clm_5C5486B86DAF.md) - 2013-09-30 to 2013-12-31 | money | total_equity | 8,951,000,000 United States dollar | superseded | [clm_E1D36B779CCD](/claim/clm_E1D36B779CCD.md) - 2013-10-16 to 2014-02-07 | money | shares_outstanding | 751,453,447 shares | superseded | [clm_2C81EE63ABD4](/claim/clm_2C81EE63ABD4.md) - 2013-12-31 to 2014-03-31 | money | cash_and_equivalents | 9,088,000,000 United States dollar | superseded | [clm_5256F0E51332](/claim/clm_5256F0E51332.md) - 2013-12-31 to 2014-12-31 | money | net_income | 4,585,000,000 United States dollar | superseded | [clm_0D677BF06F5F](/claim/clm_0D677BF06F5F.md) - 2013-12-31 to 2014-12-31 | money | operating_income | 6,562,000,000 United States dollar | superseded | [clm_77282AD1D2F3](/claim/clm_77282AD1D2F3.md) - 2013-12-31 to 2014-12-31 | money | research_and_development | 3,071,000,000 United States dollar | superseded | [clm_500DE04B5529](/claim/clm_500DE04B5529.md) - 2013-12-31 to 2014-12-31 | money | revenue | 86,623,000,000 United States dollar | superseded | [clm_D68CE9F3EC16](/claim/clm_D68CE9F3EC16.md) - 2013-12-31 to 2014-03-31 | money | total_assets | 92,663,000,000 United States dollar | superseded | [clm_ADD7AEB03348](/claim/clm_ADD7AEB03348.md) - 2013-12-31 to 2014-03-31 | money | total_equity | 14,875,000,000 United States dollar | superseded | [clm_95D9D920900D](/claim/clm_95D9D920900D.md) ## 2014 - 2014-02-07 to 2014-04-16 | money | shares_outstanding | 743,404,506 shares | superseded | [clm_0A7B9084D558](/claim/clm_0A7B9084D558.md) - 2014-03-31 to 2014-06-30 | money | cash_and_equivalents | 6,942,000,000 United States dollar | superseded | [clm_B4A00795C2AD](/claim/clm_B4A00795C2AD.md) - 2014-03-31 to 2014-06-30 | money | quarterly_net_income | 965,000,000 United States dollar | superseded | [clm_A33C6E56213F](/claim/clm_A33C6E56213F.md) - 2014-03-31 to 2014-06-30 | money | quarterly_operating_income | 1,542,000,000 United States dollar | superseded | [clm_A570DD46323D](/claim/clm_A570DD46323D.md) - 2014-03-31 to 2014-06-30 | money | quarterly_research_and_development | 809,000,000 United States dollar | superseded | [clm_5E6CD8A1C59F](/claim/clm_5E6CD8A1C59F.md) - 2014-03-31 to 2014-06-30 | money | quarterly_revenue | 20,465,000,000 United States dollar | superseded | [clm_D4699F2814E6](/claim/clm_D4699F2814E6.md) - 2014-03-31 to 2014-06-30 | money | total_assets | 91,575,000,000 United States dollar | superseded | [clm_0F21C12A3CE3](/claim/clm_0F21C12A3CE3.md) - 2014-03-31 to 2014-06-30 | money | total_equity | 14,520,000,000 United States dollar | superseded | [clm_25C0B7926A82](/claim/clm_25C0B7926A82.md) - 2014-04-16 to 2014-07-16 | money | shares_outstanding | 729,224,508 shares | superseded | [clm_EBD3870A6B63](/claim/clm_EBD3870A6B63.md) - 2014-06-30 to 2014-09-30 | money | cash_and_equivalents | 7,533,000,000 United States dollar | superseded | [clm_54D9EDE8BD17](/claim/clm_54D9EDE8BD17.md) - 2014-06-30 to 2014-09-30 | money | quarterly_net_income | 1,653,000,000 United States dollar | superseded | [clm_A49CD5A01226](/claim/clm_A49CD5A01226.md) - 2014-06-30 to 2014-09-30 | money | quarterly_operating_income | 1,787,000,000 United States dollar | superseded | [clm_A41EC06A82B5](/claim/clm_A41EC06A82B5.md) - 2014-06-30 to 2014-09-30 | money | quarterly_research_and_development | 733,000,000 United States dollar | superseded | [clm_54F1EF67A492](/claim/clm_54F1EF67A492.md) - 2014-06-30 to 2014-09-30 | money | quarterly_revenue | 22,045,000,000 United States dollar | superseded | [clm_A310ACD25BAB](/claim/clm_A310ACD25BAB.md) - 2014-06-30 to 2014-09-30 | money | total_assets | 92,737,000,000 United States dollar | superseded | [clm_50DB508F03A5](/claim/clm_50DB508F03A5.md) - 2014-06-30 to 2014-09-30 | money | total_equity | 14,061,000,000 United States dollar | superseded | [clm_D8CFD1A3F713](/claim/clm_D8CFD1A3F713.md) - 2014-07-16 to 2014-10-15 | money | shares_outstanding | 720,613,065 shares | superseded | [clm_3576C7F3EC95](/claim/clm_3576C7F3EC95.md) - 2014-09-30 to 2014-12-31 | money | cash_and_equivalents | 6,655,000,000 United States dollar | superseded | [clm_39B3B9633B70](/claim/clm_39B3B9633B70.md) - 2014-09-30 to 2015-03-31 | money | quarterly_net_income | 1,362,000,000 United States dollar | superseded | [clm_AAC88153F6CC](/claim/clm_AAC88153F6CC.md) - 2014-09-30 to 2015-03-31 | money | quarterly_operating_income | 2,119,000,000 United States dollar | superseded | [clm_2A3BF2506D6C](/claim/clm_2A3BF2506D6C.md) - 2014-09-30 to 2015-03-31 | money | quarterly_research_and_development | 750,000,000 United States dollar | superseded | [clm_AE2EC670F994](/claim/clm_AE2EC670F994.md) - 2014-09-30 to 2015-03-31 | money | quarterly_revenue | 23,784,000,000 United States dollar | superseded | [clm_09D5227EF845](/claim/clm_09D5227EF845.md) - 2014-09-30 to 2014-12-31 | money | total_assets | 92,653,000,000 United States dollar | superseded | [clm_3562205A040B](/claim/clm_3562205A040B.md) - 2014-09-30 to 2014-12-31 | money | total_equity | 14,511,000,000 United States dollar | superseded | [clm_A4A52452EC9E](/claim/clm_A4A52452EC9E.md) - 2014-10-15 to 2015-02-05 | money | shares_outstanding | 712,930,459 shares | superseded | [clm_697BE342768D](/claim/clm_697BE342768D.md) - 2014-12-31 to 2015-03-31 | money | cash_and_equivalents | 11,733,000,000 United States dollar | superseded | [clm_7714B8ECE5FD](/claim/clm_7714B8ECE5FD.md) - 2014-12-31 to 2015-12-31 | money | net_income | 5,446,000,000 United States dollar | superseded | [clm_40E4DD1C3FEB](/claim/clm_40E4DD1C3FEB.md) - 2014-12-31 to 2015-12-31 | money | operating_income | 7,473,000,000 United States dollar | superseded | [clm_F26778E06063](/claim/clm_F26778E06063.md) - 2014-12-31 to 2015-12-31 | money | research_and_development | 3,047,000,000 United States dollar | superseded | [clm_EB4602FB2B20](/claim/clm_EB4602FB2B20.md) - 2014-12-31 to 2015-12-31 | money | revenue | 90,762,000,000 United States dollar | superseded | [clm_4369DCFF965B](/claim/clm_4369DCFF965B.md) - 2014-12-31 to 2015-03-31 | money | total_assets | 99,198,000,000 United States dollar | superseded | [clm_F3E76279E3AF](/claim/clm_F3E76279E3AF.md) - 2014-12-31 to 2015-03-31 | money | total_equity | 8,665,000,000 United States dollar | superseded | [clm_2B4D26FA14C7](/claim/clm_2B4D26FA14C7.md) ## 2015 - 2015-02-05 to 2015-04-15 | money | shares_outstanding | 704,387,613 shares | superseded | [clm_D62EEFE5E1DB](/claim/clm_D62EEFE5E1DB.md) - 2015-03-31 to 2015-06-30 | money | cash_and_equivalents | 8,655,000,000 United States dollar | superseded | [clm_DDC17B812BF0](/claim/clm_DDC17B812BF0.md) - 2015-03-31 to 2015-06-30 | money | quarterly_net_income | 1,336,000,000 United States dollar | superseded | [clm_67256C17184A](/claim/clm_67256C17184A.md) - 2015-03-31 to 2015-06-30 | money | quarterly_operating_income | 2,019,000,000 United States dollar | superseded | [clm_86C585EFD667](/claim/clm_86C585EFD667.md) - 2015-03-31 to 2015-06-30 | money | quarterly_research_and_development | 769,000,000 United States dollar | superseded | [clm_276A76C638A1](/claim/clm_276A76C638A1.md) - 2015-03-31 to 2015-06-30 | money | quarterly_revenue | 22,149,000,000 United States dollar | superseded | [clm_6E9EBFF0E663](/claim/clm_6E9EBFF0E663.md) - 2015-03-31 to 2015-06-30 | money | total_assets | 97,775,000,000 United States dollar | superseded | [clm_4927724CB35F](/claim/clm_4927724CB35F.md) - 2015-03-31 to 2015-06-30 | money | total_equity | 7,906,000,000 United States dollar | superseded | [clm_8BE5C1DA3DDE](/claim/clm_8BE5C1DA3DDE.md) - 2015-04-15 to 2015-07-15 | money | shares_outstanding | 691,517,301 shares | superseded | [clm_74DB91EC60AC](/claim/clm_74DB91EC60AC.md) - 2015-06-30 to 2015-09-30 | money | cash_and_equivalents | 9,157,000,000 United States dollar | superseded | [clm_C67389EC2408](/claim/clm_C67389EC2408.md) - 2015-06-30 to 2015-09-30 | money | quarterly_net_income | 1,110,000,000 United States dollar | superseded | [clm_D21D2E6112C3](/claim/clm_D21D2E6112C3.md) - 2015-06-30 to 2015-09-30 | money | quarterly_operating_income | 1,683,000,000 United States dollar | superseded | [clm_0ADF0A7EB660](/claim/clm_0ADF0A7EB660.md) - 2015-06-30 to 2015-09-30 | money | quarterly_research_and_development | 800,000,000 United States dollar | superseded | [clm_9CADB09CC191](/claim/clm_9CADB09CC191.md) - 2015-06-30 to 2015-09-30 | money | quarterly_revenue | 24,543,000,000 United States dollar | superseded | [clm_A4B8D4C12548](/claim/clm_A4B8D4C12548.md) - 2015-06-30 to 2015-09-30 | money | total_assets | 98,102,000,000 United States dollar | superseded | [clm_E7F6CDA9D71C](/claim/clm_E7F6CDA9D71C.md) - 2015-06-30 to 2015-09-30 | money | total_equity | 6,264,000,000 United States dollar | superseded | [clm_5F9651E1C0E6](/claim/clm_5F9651E1C0E6.md) - 2015-07-15 to 2015-10-14 | money | shares_outstanding | 679,495,119 shares | superseded | [clm_DF781200398C](/claim/clm_DF781200398C.md) - 2015-09-30 to 2015-12-31 | money | cash_and_equivalents | 9,383,000,000 United States dollar | superseded | [clm_F89CAEBBA231](/claim/clm_F89CAEBBA231.md) - 2015-09-30 to 2016-03-31 | money | quarterly_net_income | 1,704,000,000 United States dollar | superseded | [clm_B34D2C602460](/claim/clm_B34D2C602460.md) - 2015-09-30 to 2016-03-31 | money | quarterly_operating_income | 2,580,000,000 United States dollar | superseded | [clm_76A6213B779D](/claim/clm_76A6213B779D.md) - 2015-09-30 to 2016-03-31 | money | quarterly_research_and_development | 857,000,000 United States dollar | superseded | [clm_3D37A1ED23AD](/claim/clm_3D37A1ED23AD.md) - 2015-09-30 to 2016-03-31 | money | quarterly_revenue | 25,849,000,000 United States dollar | superseded | [clm_2BC455B3AD9B](/claim/clm_2BC455B3AD9B.md) - 2015-09-30 to 2015-12-31 | money | total_assets | 98,998,000,000 United States dollar | superseded | [clm_5932C9E3A4B8](/claim/clm_5932C9E3A4B8.md) - 2015-09-30 to 2015-12-31 | money | total_equity | 6,740,000,000 United States dollar | superseded | [clm_435E28FF77A0](/claim/clm_435E28FF77A0.md) - 2015-10-14 to 2016-02-04 | money | shares_outstanding | 669,983,631 shares | superseded | [clm_97138E6959AE](/claim/clm_97138E6959AE.md) - 2015-12-31 to 2016-03-31 | money | cash_and_equivalents | 11,302,000,000 United States dollar | superseded | [clm_362DC9614976](/claim/clm_362DC9614976.md) - 2015-12-31 to 2016-12-31 | money | net_income | 5,176,000,000 United States dollar | superseded | [clm_0F67CE94ED94](/claim/clm_0F67CE94ED94.md) - 2015-12-31 to 2016-12-31 | money | operating_income | 7,443,000,000 United States dollar | superseded | [clm_AA7A456DB923](/claim/clm_AA7A456DB923.md) - 2015-12-31 to 2016-12-31 | money | research_and_development | 3,331,000,000 United States dollar | superseded | [clm_9CE6F3DCC12D](/claim/clm_9CE6F3DCC12D.md) - 2015-12-31 to 2016-12-31 | money | revenue | 96,114,000,000 United States dollar | superseded | [clm_F872B93D4CA0](/claim/clm_F872B93D4CA0.md) - 2015-12-31 to 2016-03-31 | money | total_assets | 94,408,000,000 United States dollar | superseded | [clm_ABDFE53B8596](/claim/clm_ABDFE53B8596.md) - 2015-12-31 to 2016-03-31 | money | total_equity | 6,335,000,000 United States dollar | superseded | [clm_642772AB6FE3](/claim/clm_642772AB6FE3.md) ## 2016 - 2016-02-04 to 2016-04-20 | money | shares_outstanding | 662,503,822 shares | superseded | [clm_AD922542B9C3](/claim/clm_AD922542B9C3.md) - 2016-03-31 to 2016-06-30 | money | cash_and_equivalents | 7,886,000,000 United States dollar | superseded | [clm_E5D90D438A8B](/claim/clm_E5D90D438A8B.md) - 2016-03-31 to 2016-06-30 | money | quarterly_net_income | 1,219,000,000 United States dollar | superseded | [clm_EDBF5513BBE6](/claim/clm_EDBF5513BBE6.md) - 2016-03-31 to 2016-06-30 | money | quarterly_operating_income | 1,788,000,000 United States dollar | superseded | [clm_34756F6DA927](/claim/clm_34756F6DA927.md) - 2016-03-31 to 2016-06-30 | money | quarterly_research_and_development | 917,000,000 United States dollar | superseded | [clm_A2DDDA9D2BA0](/claim/clm_A2DDDA9D2BA0.md) - 2016-03-31 to 2016-06-30 | money | quarterly_revenue | 22,632,000,000 United States dollar | superseded | [clm_120F9C342F45](/claim/clm_120F9C342F45.md) - 2016-03-31 to 2016-06-30 | money | total_assets | 91,547,000,000 United States dollar | superseded | [clm_57355B95454E](/claim/clm_57355B95454E.md) - 2016-03-31 to 2016-06-30 | money | total_equity | 4,043,000,000 United States dollar | superseded | [clm_DCFCC37D6B33](/claim/clm_DCFCC37D6B33.md) - 2016-04-20 to 2016-07-20 | money | shares_outstanding | 637,011,143 shares | superseded | [clm_203ECAEA0297](/claim/clm_203ECAEA0297.md) - 2016-06-30 to 2016-09-30 | money | cash_and_equivalents | 8,605,000,000 United States dollar | superseded | [clm_06D97E83DCF6](/claim/clm_06D97E83DCF6.md) - 2016-06-30 to 2016-09-30 | money | quarterly_net_income | -234,000,000 United States dollar | superseded | [clm_703615E7E747](/claim/clm_703615E7E747.md) - 2016-06-30 to 2016-09-30 | money | quarterly_operating_income | -419,000,000 United States dollar | superseded | [clm_8A47893416E2](/claim/clm_8A47893416E2.md) - 2016-06-30 to 2016-09-30 | money | quarterly_research_and_development | 2,127,000,000 United States dollar | superseded | [clm_C89573D21E88](/claim/clm_C89573D21E88.md) - 2016-06-30 to 2016-09-30 | money | quarterly_revenue | 24,755,000,000 United States dollar | superseded | [clm_C01E97BD932E](/claim/clm_C01E97BD932E.md) - 2016-06-30 to 2016-09-30 | money | total_assets | 89,609,000,000 United States dollar | superseded | [clm_1872E1157F68](/claim/clm_1872E1157F68.md) - 2016-06-30 to 2016-09-30 | money | total_equity | 585,000,000 United States dollar | superseded | [clm_A1552DF6C102](/claim/clm_A1552DF6C102.md) - 2016-07-20 to 2016-10-19 | money | shares_outstanding | 623,825,935 shares | superseded | [clm_E387D45726D3](/claim/clm_E387D45726D3.md) - 2016-09-30 to 2016-12-31 | money | cash_and_equivalents | 8,986,000,000 United States dollar | superseded | [clm_094E62CB536C](/claim/clm_094E62CB536C.md) - 2016-09-30 to 2017-03-31 | money | quarterly_net_income | 2,279,000,000 United States dollar | superseded | [clm_EF89DE063604](/claim/clm_EF89DE063604.md) - 2016-09-30 to 2017-03-31 | money | quarterly_operating_income | 2,282,000,000 United States dollar | superseded | [clm_E8B8BDCA4EE6](/claim/clm_E8B8BDCA4EE6.md) - 2016-09-30 to 2017-03-31 | money | quarterly_research_and_development | 857,000,000 United States dollar | superseded | [clm_35213B255CC3](/claim/clm_35213B255CC3.md) - 2016-09-30 to 2017-03-31 | money | quarterly_revenue | 23,898,000,000 United States dollar | superseded | [clm_3102BB5FB2E9](/claim/clm_3102BB5FB2E9.md) - 2016-09-30 to 2016-12-31 | money | total_assets | 88,950,000,000 United States dollar | superseded | [clm_4817B69FBBDC](/claim/clm_4817B69FBBDC.md) - 2016-09-30 to 2016-12-31 | money | total_equity | 2,089,000,000 United States dollar | superseded | [clm_61A517DBEAD4](/claim/clm_61A517DBEAD4.md) - 2016-10-19 to 2017-02-01 | money | shares_outstanding | 617,165,902 shares | superseded | [clm_73D9D31FB30D](/claim/clm_73D9D31FB30D.md) - 2016-12-31 to 2017-03-31 | money | cash_and_equivalents | 8,801,000,000 United States dollar | superseded | [clm_D13522C5002D](/claim/clm_D13522C5002D.md) - 2016-12-31 to 2017-12-31 | money | net_income | 4,895,000,000 United States dollar | superseded | [clm_037D9E8F668E](/claim/clm_037D9E8F668E.md) - 2016-12-31 to 2017-12-31 | money | operating_income | 5,834,000,000 United States dollar | superseded | [clm_4B3562F9CE38](/claim/clm_4B3562F9CE38.md) - 2016-12-31 to 2017-12-31 | money | research_and_development | 4,627,000,000 United States dollar | superseded | [clm_388089F372BA](/claim/clm_388089F372BA.md) - 2016-12-31 to 2017-12-31 | money | revenue | 94,571,000,000 United States dollar | superseded | [clm_D8284EE7E036](/claim/clm_D8284EE7E036.md) - 2016-12-31 to 2017-03-31 | money | total_assets | 89,997,000,000 United States dollar | superseded | [clm_8B3A8E84EB6D](/claim/clm_8B3A8E84EB6D.md) - 2016-12-31 to 2017-03-31 | money | total_equity | 817,000,000 United States dollar | superseded | [clm_4260655C0497](/claim/clm_4260655C0497.md) ## 2017 - 2017-02-01 to 2017-04-19 | money | shares_outstanding | 612,478,643 shares | superseded | [clm_294A2F65D205](/claim/clm_294A2F65D205.md) - 2017-03-31 to 2017-06-30 | money | cash_and_equivalents | 8,190,000,000 United States dollar | superseded | [clm_26D80E99F113](/claim/clm_26D80E99F113.md) - 2017-03-31 to 2017-06-30 | money | quarterly_net_income | 1,451,000,000 United States dollar | superseded | [clm_24D3E5934BFF](/claim/clm_24D3E5934BFF.md) - 2017-03-31 to 2017-06-30 | money | quarterly_operating_income | 2,024,000,000 United States dollar | superseded | [clm_86E0A359491D](/claim/clm_86E0A359491D.md) - 2017-03-31 to 2017-06-30 | money | quarterly_research_and_development | 838,000,000 United States dollar | superseded | [clm_4967AEA42F49](/claim/clm_4967AEA42F49.md) - 2017-03-31 to 2017-06-30 | money | quarterly_revenue | 20,976,000,000 United States dollar | superseded | [clm_9C1403F43C35](/claim/clm_9C1403F43C35.md) - 2017-03-31 to 2017-06-30 | money | total_assets | 89,673,000,000 United States dollar | superseded | [clm_6739BA1E06ED](/claim/clm_6739BA1E06ED.md) - 2017-03-31 to 2017-06-30 | money | total_equity | 95,000,000 United States dollar | superseded | [clm_B66767BD9A67](/claim/clm_B66767BD9A67.md) - 2017-04-19 to 2017-07-19 | money | shares_outstanding | 603,580,992 shares | superseded | [clm_E5D3729C0E1D](/claim/clm_E5D3729C0E1D.md) - 2017-06-30 to 2017-09-30 | money | cash_and_equivalents | 8,737,000,000 United States dollar | superseded | [clm_DC95C6D30760](/claim/clm_DC95C6D30760.md) - 2017-06-30 to 2017-09-30 | money | quarterly_net_income | 1,761,000,000 United States dollar | superseded | [clm_A0EBF1C87E91](/claim/clm_A0EBF1C87E91.md) - 2017-06-30 to 2017-09-30 | money | quarterly_operating_income | 2,535,000,000 United States dollar | superseded | [clm_06290F057A05](/claim/clm_06290F057A05.md) - 2017-06-30 to 2017-09-30 | money | quarterly_research_and_development | 813,000,000 United States dollar | superseded | [clm_7881F08BA87E](/claim/clm_7881F08BA87E.md) - 2017-06-30 to 2017-09-30 | money | quarterly_revenue | 22,739,000,000 United States dollar | superseded | [clm_497AA7133348](/claim/clm_497AA7133348.md) - 2017-06-30 to 2017-09-30 | money | total_assets | 90,036,000,000 United States dollar | superseded | [clm_041907FAD6CE](/claim/clm_041907FAD6CE.md) - 2017-06-30 to 2017-09-30 | money | total_equity | -2,037,000,000 United States dollar | superseded | [clm_7B93E432BA70](/claim/clm_7B93E432BA70.md) - 2017-07-19 to 2017-10-18 | money | shares_outstanding | 591,083,386 shares | superseded | [clm_08A5CBAB7B04](/claim/clm_08A5CBAB7B04.md) - 2017-09-30 to 2017-12-31 | money | cash_and_equivalents | 8,569,000,000 United States dollar | superseded | [clm_64E513D5495D](/claim/clm_64E513D5495D.md) - 2017-09-30 to 2018-03-31 | money | quarterly_net_income | 1,853,000,000 United States dollar | superseded | [clm_ED9A6AA2233E](/claim/clm_ED9A6AA2233E.md) - 2017-09-30 to 2018-03-31 | money | quarterly_operating_income | 2,689,000,000 United States dollar | superseded | [clm_4EDBD1DFB9FD](/claim/clm_4EDBD1DFB9FD.md) - 2017-09-30 to 2018-03-31 | money | quarterly_research_and_development | 767,000,000 United States dollar | superseded | [clm_65D832AFFED4](/claim/clm_65D832AFFED4.md) - 2017-09-30 to 2018-03-31 | money | quarterly_revenue | 24,309,000,000 United States dollar | superseded | [clm_95D648042C68](/claim/clm_95D648042C68.md) - 2017-09-30 to 2017-12-31 | money | total_assets | 91,007,000,000 United States dollar | superseded | [clm_DCAEAB406C22](/claim/clm_DCAEAB406C22.md) - 2017-09-30 to 2017-12-31 | money | total_equity | 1,086,000,000 United States dollar | superseded | [clm_F8F42154C547](/claim/clm_F8F42154C547.md) - 2017-10-18 to 2018-02-05 | money | shares_outstanding | 595,578,523 shares | superseded | [clm_EE9F9B31B30C](/claim/clm_EE9F9B31B30C.md) - 2017-12-31 to 2018-03-31 | money | cash_and_equivalents | 8,813,000,000 United States dollar | superseded | [clm_90EA2A48F00A](/claim/clm_90EA2A48F00A.md) - 2017-12-31 to 2018-12-31 | money | net_income | 8,197,000,000 United States dollar | superseded | [clm_43D8EE3D420D](/claim/clm_43D8EE3D420D.md) - 2017-12-31 to 2018-12-31 | money | operating_income | 10,278,000,000 United States dollar | superseded | [clm_228BFFAAE874](/claim/clm_228BFFAAE874.md) - 2017-12-31 to 2018-12-31 | money | research_and_development | 3,179,000,000 United States dollar | superseded | [clm_5E901E9A24C5](/claim/clm_5E901E9A24C5.md) - 2017-12-31 to 2018-12-31 | money | revenue | 93,392,000,000 United States dollar | superseded | [clm_E8D329307987](/claim/clm_E8D329307987.md) - 2017-12-31 to 2018-03-31 | money | total_assets | 92,333,000,000 United States dollar | superseded | [clm_7859253C9EB7](/claim/clm_7859253C9EB7.md) - 2017-12-31 to 2018-03-31 | money | total_equity | 355,000,000 United States dollar | superseded | [clm_C99E2C9E7B5F](/claim/clm_C99E2C9E7B5F.md) ## 2018 - 2018-02-05 to 2018-04-18 | money | shares_outstanding | 588,490,313 shares | superseded | [clm_327ED42D42A8](/claim/clm_327ED42D42A8.md) - 2018-03-31 to 2018-06-30 | money | cash_and_equivalents | 9,235,000,000 United States dollar | superseded | [clm_4C7AE9EEA32E](/claim/clm_4C7AE9EEA32E.md) - 2018-03-31 to 2018-06-30 | money | quarterly_net_income | 2,477,000,000 United States dollar | superseded | [clm_F004E788821C](/claim/clm_F004E788821C.md) - 2018-03-31 to 2018-06-30 | money | quarterly_operating_income | 2,875,000,000 United States dollar | superseded | [clm_A9EB133468B4](/claim/clm_A9EB133468B4.md) - 2018-03-31 to 2018-06-30 | money | quarterly_research_and_development | 764,000,000 United States dollar | superseded | [clm_F3984D00B8B3](/claim/clm_F3984D00B8B3.md) - 2018-03-31 to 2018-06-30 | money | quarterly_revenue | 23,382,000,000 United States dollar | superseded | [clm_B924FE6F02F9](/claim/clm_B924FE6F02F9.md) - 2018-03-31 to 2018-06-30 | money | total_assets | 113,549,000,000 United States dollar | superseded | [clm_36E19FE1843E](/claim/clm_36E19FE1843E.md) - 2018-03-31 to 2018-06-30 | money | total_equity | 1,222,000,000 United States dollar | superseded | [clm_E37E93ED3841](/claim/clm_E37E93ED3841.md) - 2018-04-18 to 2018-07-18 | money | shares_outstanding | 582,580,973 shares | superseded | [clm_0ED47407966F](/claim/clm_0ED47407966F.md) - 2018-06-30 to 2018-09-30 | money | cash_and_equivalents | 8,121,000,000 United States dollar | superseded | [clm_605DF3FDFCB9](/claim/clm_605DF3FDFCB9.md) - 2018-06-30 to 2018-09-30 | money | quarterly_net_income | 2,196,000,000 United States dollar | superseded | [clm_0809B84C8C9D](/claim/clm_0809B84C8C9D.md) - 2018-06-30 to 2018-09-30 | money | quarterly_operating_income | 2,710,000,000 United States dollar | superseded | [clm_681A0E60A4D5](/claim/clm_681A0E60A4D5.md) - 2018-06-30 to 2018-09-30 | money | quarterly_research_and_development | 827,000,000 United States dollar | superseded | [clm_361DA057422C](/claim/clm_361DA057422C.md) - 2018-06-30 to 2018-09-30 | money | quarterly_revenue | 24,258,000,000 United States dollar | superseded | [clm_9E8E0CE04523](/claim/clm_9E8E0CE04523.md) - 2018-06-30 to 2018-09-30 | money | total_assets | 113,195,000,000 United States dollar | superseded | [clm_65BFAC1DDAD9](/claim/clm_65BFAC1DDAD9.md) - 2018-06-30 to 2018-09-30 | money | total_equity | -1,441,000,000 United States dollar | superseded | [clm_48E647D8F526](/claim/clm_48E647D8F526.md) - 2018-07-18 to 2018-10-17 | money | shares_outstanding | 574,508,314 shares | superseded | [clm_E69FBC2761E6](/claim/clm_E69FBC2761E6.md) - 2018-09-30 to 2018-12-31 | money | cash_and_equivalents | 8,034,000,000 United States dollar | superseded | [clm_A417590285D8](/claim/clm_A417590285D8.md) - 2018-09-30 to 2019-03-31 | money | quarterly_net_income | 2,363,000,000 United States dollar | superseded | [clm_E5A71B80E9EA](/claim/clm_E5A71B80E9EA.md) - 2018-09-30 to 2019-03-31 | money | quarterly_operating_income | 2,227,000,000 United States dollar | superseded | [clm_28F515780759](/claim/clm_28F515780759.md) - 2018-09-30 to 2019-03-31 | money | quarterly_research_and_development | 826,000,000 United States dollar | superseded | [clm_579D5D9041B4](/claim/clm_579D5D9041B4.md) - 2018-09-30 to 2019-03-31 | money | quarterly_revenue | 25,146,000,000 United States dollar | superseded | [clm_E2882A70CFE7](/claim/clm_E2882A70CFE7.md) - 2018-09-30 to 2018-12-31 | money | total_assets | 114,659,000,000 United States dollar | superseded | [clm_DCAB766B3B00](/claim/clm_DCAB766B3B00.md) - 2018-09-30 to 2018-12-31 | money | total_equity | -1,289,000,000 United States dollar | superseded | [clm_94C1BDE4EAFE](/claim/clm_94C1BDE4EAFE.md) - 2018-10-17 to 2019-02-01 | money | shares_outstanding | 567,885,369 shares | superseded | [clm_482DB9AE8A41](/claim/clm_482DB9AE8A41.md) - 2018-12-31 to 2019-03-31 | money | cash_and_equivalents | 7,637,000,000 United States dollar | superseded | [clm_B84925D0A0A7](/claim/clm_B84925D0A0A7.md) - 2018-12-31 to 2019-12-31 | money | net_income | 10,460,000,000 United States dollar | superseded | [clm_B18CAC3268D7](/claim/clm_B18CAC3268D7.md) - 2018-12-31 to 2019-12-31 | money | operating_income | 11,987,000,000 United States dollar | superseded | [clm_2F2E44498204](/claim/clm_2F2E44498204.md) - 2018-12-31 to 2019-12-31 | money | research_and_development | 3,269,000,000 United States dollar | superseded | [clm_CEFC74F3C5F4](/claim/clm_CEFC74F3C5F4.md) - 2018-12-31 to 2019-12-31 | money | revenue | 101,127,000,000 United States dollar | superseded | [clm_9E545FA26B3B](/claim/clm_9E545FA26B3B.md) - 2018-12-31 to 2019-03-31 | money | total_assets | 117,359,000,000 United States dollar | superseded | [clm_C6EAF7228924](/claim/clm_C6EAF7228924.md) - 2018-12-31 to 2019-03-31 | money | total_equity | 339,000,000 United States dollar | superseded | [clm_79A5F55DCCCC](/claim/clm_79A5F55DCCCC.md) ## 2019 - 2019-02-01 to 2019-04-17 | money | shares_outstanding | 564,985,109 shares | superseded | [clm_23F91BC50212](/claim/clm_23F91BC50212.md) - 2019-03-31 to 2019-06-30 | money | cash_and_equivalents | 6,836,000,000 United States dollar | superseded | [clm_270CC0429953](/claim/clm_270CC0429953.md) - 2019-03-31 to 2019-06-30 | money | quarterly_net_income | 2,149,000,000 United States dollar | superseded | [clm_5C8FD553E241](/claim/clm_5C8FD553E241.md) - 2019-03-31 to 2019-06-30 | money | quarterly_operating_income | 2,350,000,000 United States dollar | superseded | [clm_65745F8BA1E6](/claim/clm_65745F8BA1E6.md) - 2019-03-31 to 2019-06-30 | money | quarterly_research_and_development | 866,000,000 United States dollar | superseded | [clm_467FB67BD75A](/claim/clm_467FB67BD75A.md) - 2019-03-31 to 2019-06-30 | money | quarterly_revenue | 22,917,000,000 United States dollar | superseded | [clm_74FA281F120D](/claim/clm_74FA281F120D.md) - 2019-03-31 to 2019-06-30 | money | total_assets | 120,209,000,000 United States dollar | superseded | [clm_C501FCCA28BD](/claim/clm_C501FCCA28BD.md) - 2019-03-31 to 2019-06-30 | money | total_equity | 125,000,000 United States dollar | superseded | [clm_7380D2E34B73](/claim/clm_7380D2E34B73.md) - 2019-04-17 to 2019-07-17 | money | shares_outstanding | 562,630,423 shares | superseded | [clm_045D5A752871](/claim/clm_045D5A752871.md) - 2019-06-30 to 2019-09-30 | money | cash_and_equivalents | 9,167,000,000 United States dollar | superseded | [clm_AE1EDBB5EEAF](/claim/clm_AE1EDBB5EEAF.md) - 2019-06-30 to 2019-09-30 | money | quarterly_net_income | -2,942,000,000 United States dollar | superseded | [clm_F8ABC3928239](/claim/clm_F8ABC3928239.md) - 2019-06-30 to 2019-09-30 | money | quarterly_operating_income | -3,380,000,000 United States dollar | superseded | [clm_BCD6B3C2E556](/claim/clm_BCD6B3C2E556.md) - 2019-06-30 to 2019-09-30 | money | quarterly_research_and_development | 826,000,000 United States dollar | superseded | [clm_FA15DFAF52B4](/claim/clm_FA15DFAF52B4.md) - 2019-06-30 to 2019-09-30 | money | quarterly_revenue | 15,751,000,000 United States dollar | superseded | [clm_B4FFE2ED3D10](/claim/clm_B4FFE2ED3D10.md) - 2019-06-30 to 2019-09-30 | money | total_assets | 126,261,000,000 United States dollar | superseded | [clm_227365B6C685](/claim/clm_227365B6C685.md) - 2019-06-30 to 2019-09-30 | money | total_equity | -5,322,000,000 United States dollar | superseded | [clm_F4DCF3F82F57](/claim/clm_F4DCF3F82F57.md) - 2019-07-17 to 2019-10-16 | money | shares_outstanding | 562,710,008 shares | superseded | [clm_F79C15BB384D](/claim/clm_F79C15BB384D.md) - 2019-09-30 to 2019-12-31 | money | cash_and_equivalents | 9,763,000,000 United States dollar | superseded | [clm_B818625024E9](/claim/clm_B818625024E9.md) - 2019-09-30 to 2020-03-31 | money | quarterly_net_income | 1,167,000,000 United States dollar | superseded | [clm_1787CED5ACF6](/claim/clm_1787CED5ACF6.md) - 2019-09-30 to 2020-03-31 | money | quarterly_operating_income | 1,259,000,000 United States dollar | superseded | [clm_B8B687B8B2C3](/claim/clm_B8B687B8B2C3.md) - 2019-09-30 to 2020-03-31 | money | quarterly_research_and_development | 778,000,000 United States dollar | superseded | [clm_60A24BABDD59](/claim/clm_60A24BABDD59.md) - 2019-09-30 to 2020-03-31 | money | quarterly_revenue | 19,980,000,000 United States dollar | superseded | [clm_EC9DC8B4296A](/claim/clm_EC9DC8B4296A.md) - 2019-09-30 to 2019-12-31 | money | total_assets | 132,598,000,000 United States dollar | superseded | [clm_664DCFB230B2](/claim/clm_664DCFB230B2.md) - 2019-09-30 to 2019-12-31 | money | total_equity | -4,116,000,000 United States dollar | superseded | [clm_4F63F81D6D3A](/claim/clm_4F63F81D6D3A.md) - 2019-10-16 to 2020-01-24 | money | shares_outstanding | 562,791,233 shares | superseded | [clm_2613C3260236](/claim/clm_2613C3260236.md) - 2019-12-31 to 2020-03-31 | money | cash_and_equivalents | 9,485,000,000 United States dollar | superseded | [clm_8EE70B716926](/claim/clm_8EE70B716926.md) - 2019-12-31 to 2020-12-31 | money | net_income | -636,000,000 United States dollar | superseded | [clm_18B3E6525945](/claim/clm_18B3E6525945.md) - 2019-12-31 to 2020-12-31 | money | operating_income | -1,975,000,000 United States dollar | superseded | [clm_60D969B1A03F](/claim/clm_60D969B1A03F.md) - 2019-12-31 to 2020-12-31 | money | research_and_development | 3,219,000,000 United States dollar | superseded | [clm_263BE317C190](/claim/clm_263BE317C190.md) - 2019-12-31 to 2020-12-31 | money | revenue | 76,559,000,000 United States dollar | superseded | [clm_BC8DEA85EC59](/claim/clm_BC8DEA85EC59.md) - 2019-12-31 to 2020-03-31 | money | total_assets | 133,625,000,000 United States dollar | superseded | [clm_8B51699C6F20](/claim/clm_8B51699C6F20.md) - 2019-12-31 to 2020-01-01 | money | total_equity | -8,617,000,000 United States dollar | superseded | [clm_353E009EF445](/claim/clm_353E009EF445.md) ## 2020 - 2020-01-01 to 2020-03-31 | money | total_equity | -8,462,000,000 United States dollar | superseded | [clm_81D2FD6640B7](/claim/clm_81D2FD6640B7.md) - 2020-01-24 to 2020-04-22 | money | shares_outstanding | 563,152,208 shares | superseded | [clm_12626416CFC5](/claim/clm_12626416CFC5.md) - 2020-03-31 to 2020-06-30 | money | cash_and_equivalents | 15,039,000,000 United States dollar | superseded | [clm_D25161B9D0FF](/claim/clm_D25161B9D0FF.md) - 2020-03-31 to 2020-06-30 | money | quarterly_net_income | -628,000,000 United States dollar | superseded | [clm_B4781D6CD9AE](/claim/clm_B4781D6CD9AE.md) - 2020-03-31 to 2020-06-30 | money | quarterly_operating_income | -1,353,000,000 United States dollar | superseded | [clm_87EEEB922D67](/claim/clm_87EEEB922D67.md) - 2020-03-31 to 2020-06-30 | money | quarterly_research_and_development | 672,000,000 United States dollar | superseded | [clm_1BA22B35B0EA](/claim/clm_1BA22B35B0EA.md) - 2020-03-31 to 2020-06-30 | money | quarterly_revenue | 16,908,000,000 United States dollar | superseded | [clm_4449BDE935B0](/claim/clm_4449BDE935B0.md) - 2020-03-31 to 2020-06-30 | money | total_assets | 143,075,000,000 United States dollar | superseded | [clm_B1202D2F6872](/claim/clm_B1202D2F6872.md) - 2020-03-31 to 2020-06-30 | money | total_equity | -9,665,000,000 United States dollar | superseded | [clm_D61F4301366E](/claim/clm_D61F4301366E.md) - 2020-04-22 to 2020-07-22 | money | shares_outstanding | 564,325,344 shares | superseded | [clm_CA43558A222D](/claim/clm_CA43558A222D.md) - 2020-06-30 to 2020-09-30 | money | cash_and_equivalents | 19,992,000,000 United States dollar | superseded | [clm_56511D8A466B](/claim/clm_56511D8A466B.md) - 2020-06-30 to 2020-09-30 | money | quarterly_net_income | -2,376,000,000 United States dollar | superseded | [clm_1D1896EF596D](/claim/clm_1D1896EF596D.md) - 2020-06-30 to 2020-09-30 | money | quarterly_operating_income | -2,964,000,000 United States dollar | superseded | [clm_2ECF78F179D6](/claim/clm_2ECF78F179D6.md) - 2020-06-30 to 2020-09-30 | money | quarterly_research_and_development | 625,000,000 United States dollar | superseded | [clm_EF468C0D0111](/claim/clm_EF468C0D0111.md) - 2020-06-30 to 2020-09-30 | money | quarterly_revenue | 11,807,000,000 United States dollar | superseded | [clm_1E0CEC650936](/claim/clm_1E0CEC650936.md) - 2020-06-30 to 2020-09-30 | money | total_assets | 162,872,000,000 United States dollar | superseded | [clm_2B2EA6C8C776](/claim/clm_2B2EA6C8C776.md) - 2020-06-30 to 2020-09-30 | money | total_equity | -11,667,000,000 United States dollar | superseded | [clm_FC9EF06FA6E1](/claim/clm_FC9EF06FA6E1.md) - 2020-07-22 to 2020-10-21 | money | shares_outstanding | 564,448,738 shares | superseded | [clm_97236C8EA854](/claim/clm_97236C8EA854.md) - 2020-09-30 to 2020-12-31 | money | cash_and_equivalents | 10,564,000,000 United States dollar | superseded | [clm_B525E9F3DB0E](/claim/clm_B525E9F3DB0E.md) - 2020-09-30 to 2021-03-31 | money | quarterly_net_income | -449,000,000 United States dollar | superseded | [clm_3BF963AA4EE4](/claim/clm_3BF963AA4EE4.md) - 2020-09-30 to 2021-03-31 | money | quarterly_operating_income | -401,000,000 United States dollar | superseded | [clm_91CEF73D6854](/claim/clm_91CEF73D6854.md) - 2020-09-30 to 2021-03-31 | money | quarterly_research_and_development | 574,000,000 United States dollar | superseded | [clm_70752ED56081](/claim/clm_70752ED56081.md) - 2020-09-30 to 2021-03-31 | money | quarterly_revenue | 14,139,000,000 United States dollar | superseded | [clm_A718E95FAF3B](/claim/clm_A718E95FAF3B.md) - 2020-09-30 to 2020-12-31 | money | total_assets | 161,261,000,000 United States dollar | superseded | [clm_634AC9461048](/claim/clm_634AC9461048.md) - 2020-09-30 to 2020-12-31 | money | total_equity | -11,821,000,000 United States dollar | superseded | [clm_0EC84212E9C1](/claim/clm_0EC84212E9C1.md) - 2020-10-21 to 2021-01-25 | money | shares_outstanding | 564,529,686 shares | superseded | [clm_1B38D5F77EDD](/claim/clm_1B38D5F77EDD.md) - 2020-12-31 to 2021-03-31 | money | cash_and_equivalents | 7,752,000,000 United States dollar | superseded | [clm_7AD02C4A97FA](/claim/clm_7AD02C4A97FA.md) - 2020-12-31 to 2021-12-31 | money | net_income | -11,873,000,000 United States dollar | superseded | [clm_92A67E1F144E](/claim/clm_92A67E1F144E.md) - 2020-12-31 to 2021-12-31 | money | operating_income | -12,767,000,000 United States dollar | superseded | [clm_B1197CD55307](/claim/clm_B1197CD55307.md) - 2020-12-31 to 2021-12-31 | money | research_and_development | 2,476,000,000 United States dollar | superseded | [clm_63896F393419](/claim/clm_63896F393419.md) - 2020-12-31 to 2021-12-31 | money | revenue | 58,158,000,000 United States dollar | superseded | [clm_82F6EC63CB66](/claim/clm_82F6EC63CB66.md) - 2020-12-31 to 2021-03-31 | money | total_assets | 152,136,000,000 United States dollar | superseded | [clm_A0CD57AF553A](/claim/clm_A0CD57AF553A.md) - 2020-12-31 to 2021-03-31 | money | total_equity | -18,316,000,000 United States dollar | superseded | [clm_40A80544B801](/claim/clm_40A80544B801.md) ## 2021 - 2021-01-25 to 2021-04-21 | money | shares_outstanding | 582,996,860 shares | superseded | [clm_FBCFDA4676D6](/claim/clm_FBCFDA4676D6.md) - 2021-03-31 to 2021-06-30 | money | cash_and_equivalents | 7,059,000,000 United States dollar | superseded | [clm_D80900D57D56](/claim/clm_D80900D57D56.md) - 2021-03-31 to 2021-06-30 | money | quarterly_net_income | -537,000,000 United States dollar | superseded | [clm_3E70FC375EA9](/claim/clm_3E70FC375EA9.md) - 2021-03-31 to 2021-06-30 | money | quarterly_operating_income | -83,000,000 United States dollar | superseded | [clm_5D10EA036644](/claim/clm_5D10EA036644.md) - 2021-03-31 to 2021-06-30 | money | quarterly_research_and_development | 499,000,000 United States dollar | superseded | [clm_55CB5A9EC50C](/claim/clm_55CB5A9EC50C.md) - 2021-03-31 to 2021-06-30 | money | quarterly_revenue | 15,217,000,000 United States dollar | superseded | [clm_A6682153CC88](/claim/clm_A6682153CC88.md) - 2021-03-31 to 2021-06-30 | money | total_assets | 150,035,000,000 United States dollar | superseded | [clm_5B1BE3A34113](/claim/clm_5B1BE3A34113.md) - 2021-03-31 to 2021-06-30 | money | total_equity | -18,058,000,000 United States dollar | superseded | [clm_557FBD79D868](/claim/clm_557FBD79D868.md) - 2021-04-21 to 2021-07-21 | money | shares_outstanding | 584,810,068 shares | superseded | [clm_27D4FC671965](/claim/clm_27D4FC671965.md) - 2021-06-30 to 2021-09-30 | money | cash_and_equivalents | 8,271,000,000 United States dollar | superseded | [clm_66AF4A6465C9](/claim/clm_66AF4A6465C9.md) - 2021-06-30 to 2021-09-30 | money | quarterly_net_income | 587,000,000 United States dollar | superseded | [clm_7D35DF16CEC0](/claim/clm_7D35DF16CEC0.md) - 2021-06-30 to 2021-09-30 | money | quarterly_operating_income | 1,023,000,000 United States dollar | superseded | [clm_099EF8A5FE3C](/claim/clm_099EF8A5FE3C.md) - 2021-06-30 to 2021-09-30 | money | quarterly_research_and_development | 497,000,000 United States dollar | superseded | [clm_8794262ED42F](/claim/clm_8794262ED42F.md) - 2021-06-30 to 2021-09-30 | money | quarterly_revenue | 16,998,000,000 United States dollar | superseded | [clm_99B3C746F3B8](/claim/clm_99B3C746F3B8.md) - 2021-06-30 to 2021-09-30 | money | total_assets | 148,935,000,000 United States dollar | superseded | [clm_B58B422B4BE8](/claim/clm_B58B422B4BE8.md) - 2021-06-30 to 2021-09-30 | money | total_equity | -16,682,000,000 United States dollar | superseded | [clm_E508C6D01E3F](/claim/clm_E508C6D01E3F.md) - 2021-07-21 to 2021-10-20 | money | shares_outstanding | 586,151,904 shares | superseded | [clm_8CA938A266A4](/claim/clm_8CA938A266A4.md) - 2021-09-30 to 2021-12-31 | money | cash_and_equivalents | 9,764,000,000 United States dollar | superseded | [clm_BC541E2A33E2](/claim/clm_BC541E2A33E2.md) - 2021-09-30 to 2022-03-31 | money | quarterly_net_income | -109,000,000 United States dollar | superseded | [clm_5658A92FA597](/claim/clm_5658A92FA597.md) - 2021-09-30 to 2022-03-31 | money | quarterly_operating_income | 329,000,000 United States dollar | superseded | [clm_8E331C737512](/claim/clm_8E331C737512.md) - 2021-09-30 to 2022-03-31 | money | quarterly_research_and_development | 575,000,000 United States dollar | superseded | [clm_686A8BF154F3](/claim/clm_686A8BF154F3.md) - 2021-09-30 to 2022-03-31 | money | quarterly_revenue | 15,278,000,000 United States dollar | superseded | [clm_5327592D5BBF](/claim/clm_5327592D5BBF.md) - 2021-09-30 to 2021-12-31 | money | total_assets | 146,846,000,000 United States dollar | superseded | [clm_6E2B7759BC2E](/claim/clm_6E2B7759BC2E.md) - 2021-09-30 to 2021-12-31 | money | total_equity | -14,440,000,000 United States dollar | superseded | [clm_58F32BFF15E9](/claim/clm_58F32BFF15E9.md) - 2021-10-20 to 2022-01-24 | money | shares_outstanding | 587,699,224 shares | superseded | [clm_E87350E3B92B](/claim/clm_E87350E3B92B.md) - 2021-12-31 to 2022-03-31 | money | cash_and_equivalents | 8,052,000,000 United States dollar | superseded | [clm_FB30AE2695D7](/claim/clm_FB30AE2695D7.md) - 2021-12-31 to 2022-12-31 | money | net_income | -4,202,000,000 United States dollar | superseded | [clm_240408248F40](/claim/clm_240408248F40.md) - 2021-12-31 to 2022-12-31 | money | operating_income | -2,902,000,000 United States dollar | superseded | [clm_8E6DC07C5CC3](/claim/clm_8E6DC07C5CC3.md) - 2021-12-31 to 2022-12-31 | money | research_and_development | 2,249,000,000 United States dollar | superseded | [clm_4AB2029896F6](/claim/clm_4AB2029896F6.md) - 2021-12-31 to 2022-12-31 | money | revenue | 62,286,000,000 United States dollar | superseded | [clm_8F6C85FEFD9B](/claim/clm_8F6C85FEFD9B.md) - 2021-12-31 to 2022-03-31 | money | total_assets | 138,552,000,000 United States dollar | superseded | [clm_C5CCAC3DB804](/claim/clm_C5CCAC3DB804.md) - 2021-12-31 to 2022-03-31 | money | total_equity | -14,999,000,000 United States dollar | superseded | [clm_DD810503D43A](/claim/clm_DD810503D43A.md) ## 2022 - 2022-01-24 to 2022-04-20 | money | shares_outstanding | 582,999,765 shares | superseded | [clm_EEA1A79B61EC](/claim/clm_EEA1A79B61EC.md) - 2022-03-31 to 2022-06-30 | money | cash_and_equivalents | 7,409,000,000 United States dollar | superseded | [clm_F9187E2660B1](/claim/clm_F9187E2660B1.md) - 2022-03-31 to 2022-06-30 | money | quarterly_net_income | -1,219,000,000 United States dollar | superseded | [clm_03615ECB36F6](/claim/clm_03615ECB36F6.md) - 2022-03-31 to 2022-06-30 | money | quarterly_operating_income | -1,169,000,000 United States dollar | superseded | [clm_87F533370706](/claim/clm_87F533370706.md) - 2022-03-31 to 2022-06-30 | money | quarterly_research_and_development | 633,000,000 United States dollar | superseded | [clm_C9CC281E4454](/claim/clm_C9CC281E4454.md) - 2022-03-31 to 2022-06-30 | money | quarterly_revenue | 13,991,000,000 United States dollar | superseded | [clm_8F7A225BDDA4](/claim/clm_8F7A225BDDA4.md) - 2022-03-31 to 2022-06-30 | money | total_assets | 135,801,000,000 United States dollar | superseded | [clm_E1FC0B1D40BF](/claim/clm_E1FC0B1D40BF.md) - 2022-03-31 to 2022-06-30 | money | total_equity | -15,398,000,000 United States dollar | superseded | [clm_86AD65A2DC30](/claim/clm_86AD65A2DC30.md) - 2022-04-20 to 2022-07-20 | money | shares_outstanding | 591,635,833 shares | superseded | [clm_C8EFA45E1243](/claim/clm_C8EFA45E1243.md) - 2022-06-30 to 2022-09-30 | money | cash_and_equivalents | 10,090,000,000 United States dollar | superseded | [clm_A90295D7085B](/claim/clm_A90295D7085B.md) - 2022-06-30 to 2022-09-30 | money | quarterly_net_income | 193,000,000 United States dollar | superseded | [clm_723E34F94429](/claim/clm_723E34F94429.md) - 2022-06-30 to 2022-09-30 | money | quarterly_operating_income | 774,000,000 United States dollar | superseded | [clm_312309FFDA47](/claim/clm_312309FFDA47.md) - 2022-06-30 to 2022-09-30 | money | quarterly_research_and_development | 698,000,000 United States dollar | superseded | [clm_F4BE39FE6612](/claim/clm_F4BE39FE6612.md) - 2022-06-30 to 2022-09-30 | money | quarterly_revenue | 16,681,000,000 United States dollar | superseded | [clm_63386432FF16](/claim/clm_63386432FF16.md) - 2022-06-30 to 2022-09-30 | money | total_assets | 135,479,000,000 United States dollar | superseded | [clm_C40ECD4157CE](/claim/clm_C40ECD4157CE.md) - 2022-06-30 to 2022-09-30 | money | total_equity | -14,888,000,000 United States dollar | superseded | [clm_C62DD5426A7C](/claim/clm_C62DD5426A7C.md) - 2022-07-20 to 2022-10-19 | money | shares_outstanding | 593,811,169 shares | superseded | [clm_6D44C4CB8281](/claim/clm_6D44C4CB8281.md) - 2022-09-30 to 2022-12-31 | money | cash_and_equivalents | 13,494,000,000 United States dollar | superseded | [clm_FD9F7B983426](/claim/clm_FD9F7B983426.md) - 2022-09-30 to 2023-03-31 | money | quarterly_net_income | -3,275,000,000 United States dollar | superseded | [clm_7FFF491F008E](/claim/clm_7FFF491F008E.md) - 2022-09-30 to 2023-03-31 | money | quarterly_operating_income | -2,799,000,000 United States dollar | superseded | [clm_61FC5EE0987C](/claim/clm_61FC5EE0987C.md) - 2022-09-30 to 2023-03-31 | money | quarterly_research_and_development | 727,000,000 United States dollar | superseded | [clm_080AC1ED6891](/claim/clm_080AC1ED6891.md) - 2022-09-30 to 2023-03-31 | money | quarterly_revenue | 15,956,000,000 United States dollar | superseded | [clm_AE2DA9470A7A](/claim/clm_AE2DA9470A7A.md) - 2022-09-30 to 2022-12-31 | money | total_assets | 137,558,000,000 United States dollar | superseded | [clm_1B28E9E50005](/claim/clm_1B28E9E50005.md) - 2022-09-30 to 2022-12-31 | money | total_equity | -17,699,000,000 United States dollar | superseded | [clm_81D9E0A11B48](/claim/clm_81D9E0A11B48.md) - 2022-10-19 to 2023-01-20 | money | shares_outstanding | 595,983,192 shares | superseded | [clm_4C29E334BEBC](/claim/clm_4C29E334BEBC.md) - 2022-12-31 to 2023-03-31 | money | cash_and_equivalents | 14,614,000,000 United States dollar | superseded | [clm_0D59BEBFFEDA](/claim/clm_0D59BEBFFEDA.md) - 2022-12-31 to 2023-12-31 | money | net_income | -4,935,000,000 United States dollar | superseded | [clm_EF31E565B640](/claim/clm_EF31E565B640.md) - 2022-12-31 to 2023-12-31 | money | operating_income | -3,547,000,000 United States dollar | superseded | [clm_FFAD0723D8E1](/claim/clm_FFAD0723D8E1.md) - 2022-12-31 to 2023-12-31 | money | research_and_development | 2,852,000,000 United States dollar | superseded | [clm_4D8A1B77EBFF](/claim/clm_4D8A1B77EBFF.md) - 2022-12-31 to 2023-12-31 | money | revenue | 66,608,000,000 United States dollar | superseded | [clm_AB3332935939](/claim/clm_AB3332935939.md) - 2022-12-31 to 2023-03-31 | money | total_assets | 137,100,000,000 United States dollar | superseded | [clm_174560614B0B](/claim/clm_174560614B0B.md) - 2022-12-31 to 2023-03-31 | money | total_equity | -15,883,000,000 United States dollar | superseded | [clm_978B482A0DA6](/claim/clm_978B482A0DA6.md) ## 2023 - 2023-01-20 to 2023-04-19 | money | shares_outstanding | 598,239,585 shares | superseded | [clm_CC7B74520F82](/claim/clm_CC7B74520F82.md) - 2023-03-31 to 2023-06-30 | money | cash_and_equivalents | 10,812,000,000 United States dollar | superseded | [clm_FC310CA9AE6E](/claim/clm_FC310CA9AE6E.md) - 2023-03-31 to 2023-06-30 | money | quarterly_net_income | -414,000,000 United States dollar | superseded | [clm_DEDA61F959AE](/claim/clm_DEDA61F959AE.md) - 2023-03-31 to 2023-06-30 | money | quarterly_operating_income | -149,000,000 United States dollar | superseded | [clm_A682C9A418D7](/claim/clm_A682C9A418D7.md) - 2023-03-31 to 2023-06-30 | money | quarterly_research_and_development | 741,000,000 United States dollar | superseded | [clm_C44B77BC781E](/claim/clm_C44B77BC781E.md) - 2023-03-31 to 2023-06-30 | money | quarterly_revenue | 17,921,000,000 United States dollar | superseded | [clm_888316BEB7E1](/claim/clm_888316BEB7E1.md) - 2023-03-31 to 2023-06-30 | money | total_assets | 136,347,000,000 United States dollar | superseded | [clm_37D88B262D8B](/claim/clm_37D88B262D8B.md) - 2023-03-31 to 2023-06-30 | money | total_equity | -15,508,000,000 United States dollar | superseded | [clm_134A0289863A](/claim/clm_134A0289863A.md) - 2023-04-19 to 2023-07-19 | money | shares_outstanding | 601,593,507 shares | superseded | [clm_E648A36F1464](/claim/clm_E648A36F1464.md) - 2023-06-30 to 2023-09-30 | money | cash_and_equivalents | 7,254,000,000 United States dollar | superseded | [clm_6F7373047335](/claim/clm_6F7373047335.md) - 2023-06-30 to 2023-09-30 | money | quarterly_net_income | -149,000,000 United States dollar | superseded | [clm_5F36A3D5FFFB](/claim/clm_5F36A3D5FFFB.md) - 2023-06-30 to 2023-09-30 | money | quarterly_operating_income | -99,000,000 United States dollar | superseded | [clm_DBC0277DE4A7](/claim/clm_DBC0277DE4A7.md) - 2023-06-30 to 2023-09-30 | money | quarterly_research_and_development | 797,000,000 United States dollar | superseded | [clm_2639F8C3D9D7](/claim/clm_2639F8C3D9D7.md) - 2023-06-30 to 2023-09-30 | money | quarterly_revenue | 19,751,000,000 United States dollar | superseded | [clm_EBC91F19F0B9](/claim/clm_EBC91F19F0B9.md) - 2023-06-30 to 2023-09-30 | money | total_assets | 134,774,000,000 United States dollar | superseded | [clm_A1982F9CD550](/claim/clm_A1982F9CD550.md) - 2023-06-30 to 2023-09-30 | money | total_equity | -15,517,000,000 United States dollar | superseded | [clm_EA39F94793B7](/claim/clm_EA39F94793B7.md) - 2023-07-19 to 2023-10-18 | money | shares_outstanding | 603,203,554 shares | superseded | [clm_940B113003EE](/claim/clm_940B113003EE.md) - 2023-09-30 to 2023-12-31 | money | cash_and_equivalents | 6,811,000,000 United States dollar | superseded | [clm_9FAD22C0811D](/claim/clm_9FAD22C0811D.md) - 2023-09-30 to 2024-03-31 | money | quarterly_net_income | -1,636,000,000 United States dollar | superseded | [clm_114C03A7FF59](/claim/clm_114C03A7FF59.md) - 2023-09-30 to 2024-03-31 | money | quarterly_operating_income | -808,000,000 United States dollar | superseded | [clm_49C937CE258A](/claim/clm_49C937CE258A.md) - 2023-09-30 to 2024-03-31 | money | quarterly_research_and_development | 958,000,000 United States dollar | superseded | [clm_F3CC2BC10196](/claim/clm_F3CC2BC10196.md) - 2023-09-30 to 2024-03-31 | money | quarterly_revenue | 18,104,000,000 United States dollar | superseded | [clm_B6789BD4B07A](/claim/clm_B6789BD4B07A.md) - 2023-09-30 to 2023-12-31 | money | total_assets | 134,281,000,000 United States dollar | superseded | [clm_4EEAF107824B](/claim/clm_4EEAF107824B.md) - 2023-09-30 to 2023-12-31 | money | total_equity | -16,729,000,000 United States dollar | superseded | [clm_E05D2B88C2A6](/claim/clm_E05D2B88C2A6.md) - 2023-10-18 to 2024-01-24 | money | shares_outstanding | 604,976,797 shares | superseded | [clm_A53D22356483](/claim/clm_A53D22356483.md) - 2023-12-31 to 2024-03-31 | money | cash_and_equivalents | 12,691,000,000 United States dollar | superseded | [clm_CEAC9B153725](/claim/clm_CEAC9B153725.md) - 2023-12-31 to 2024-12-31 | money | net_income | -2,222,000,000 United States dollar | superseded | [clm_025526E92FCA](/claim/clm_025526E92FCA.md) - 2023-12-31 to 2024-12-31 | money | operating_income | -773,000,000 United States dollar | superseded | [clm_CF01F40C7713](/claim/clm_CF01F40C7713.md) - 2023-12-31 to 2024-12-31 | money | research_and_development | 3,377,000,000 United States dollar | superseded | [clm_F2095CDF457D](/claim/clm_F2095CDF457D.md) - 2023-12-31 to 2024-12-31 | money | revenue | 77,794,000,000 United States dollar | superseded | [clm_B366A53E683D](/claim/clm_B366A53E683D.md) - 2023-12-31 to 2024-03-31 | money | total_assets | 137,012,000,000 United States dollar | superseded | [clm_FB4664CE623D](/claim/clm_FB4664CE623D.md) - 2023-12-31 to 2024-03-31 | money | total_equity | -17,233,000,000 United States dollar | superseded | [clm_62406E55A438](/claim/clm_62406E55A438.md) ## 2024 - 2024-01-01 | people | chair | Steven M. Mollenkopf | valid | [clm_1D09B2F697F5](/claim/clm_1D09B2F697F5.md) - 2024-01-24 to 2024-04-17 | money | shares_outstanding | 610,135,205 shares | superseded | [clm_76B31E53B80A](/claim/clm_76B31E53B80A.md) - 2024-03-31 to 2024-06-30 | money | cash_and_equivalents | 6,914,000,000 United States dollar | superseded | [clm_1827DF196477](/claim/clm_1827DF196477.md) - 2024-03-31 to 2024-06-30 | money | quarterly_net_income | -343,000,000 United States dollar | superseded | [clm_A8E9CF6F23EC](/claim/clm_A8E9CF6F23EC.md) - 2024-03-31 to 2024-06-30 | money | quarterly_operating_income | -86,000,000 United States dollar | superseded | [clm_51BDFDD74434](/claim/clm_51BDFDD74434.md) - 2024-03-31 to 2024-06-30 | money | quarterly_research_and_development | 868,000,000 United States dollar | superseded | [clm_620A94A04B88](/claim/clm_620A94A04B88.md) - 2024-03-31 to 2024-06-30 | money | quarterly_revenue | 16,569,000,000 United States dollar | superseded | [clm_C08BB3DBED56](/claim/clm_C08BB3DBED56.md) - 2024-03-31 to 2024-06-30 | money | total_assets | 134,484,000,000 United States dollar | superseded | [clm_82493D7CC975](/claim/clm_82493D7CC975.md) - 2024-03-31 to 2024-06-30 | money | total_equity | -17,009,000,000 United States dollar | superseded | [clm_50C2ED2E64F3](/claim/clm_50C2ED2E64F3.md) - 2024-04-17 to 2024-07-24 | money | shares_outstanding | 613,884,224 shares | superseded | [clm_D2E3E6F37AFD](/claim/clm_D2E3E6F37AFD.md) - 2024-06-30 to 2024-09-30 | money | cash_and_equivalents | 10,894,000,000 United States dollar | superseded | [clm_815BCDA254BB](/claim/clm_815BCDA254BB.md) - 2024-06-30 to 2024-09-30 | money | quarterly_net_income | -1,439,000,000 United States dollar | superseded | [clm_6527685684C8](/claim/clm_6527685684C8.md) - 2024-06-30 to 2024-09-30 | money | quarterly_operating_income | -1,090,000,000 United States dollar | superseded | [clm_3E394C24E0F9](/claim/clm_3E394C24E0F9.md) - 2024-06-30 to 2024-09-30 | money | quarterly_research_and_development | 954,000,000 United States dollar | superseded | [clm_D477CA23CE64](/claim/clm_D477CA23CE64.md) - 2024-06-30 to 2024-09-30 | money | quarterly_revenue | 16,866,000,000 United States dollar | superseded | [clm_33792D762B29](/claim/clm_33792D762B29.md) - 2024-06-30 to 2024-09-30 | money | total_assets | 142,720,000,000 United States dollar | superseded | [clm_508C52C536DF](/claim/clm_508C52C536DF.md) - 2024-06-30 to 2024-09-30 | money | total_equity | -17,976,000,000 United States dollar | superseded | [clm_ADCD1D37618F](/claim/clm_ADCD1D37618F.md) - 2024-07-24 to 2024-10-16 | money | shares_outstanding | 616,167,165 shares | superseded | [clm_35C070E1E6B1](/claim/clm_35C070E1E6B1.md) - 2024-08-08 | people | ceo | Kelly Ortberg | valid | [clm_7FD39C335742](/claim/clm_7FD39C335742.md) - 2024-09-30 to 2024-12-31 | money | cash_and_equivalents | 9,961,000,000 United States dollar | superseded | [clm_0A9CC72B3EAE](/claim/clm_0A9CC72B3EAE.md) - 2024-09-30 to 2025-03-31 | money | quarterly_net_income | -6,170,000,000 United States dollar | superseded | [clm_AF9750DDBB88](/claim/clm_AF9750DDBB88.md) - 2024-09-30 to 2025-03-31 | money | quarterly_operating_income | -5,761,000,000 United States dollar | superseded | [clm_50CC81D18449](/claim/clm_50CC81D18449.md) - 2024-09-30 to 2025-03-31 | money | quarterly_research_and_development | 1,154,000,000 United States dollar | superseded | [clm_A06511C4AD09](/claim/clm_A06511C4AD09.md) - 2024-09-30 to 2025-03-31 | money | quarterly_revenue | 17,840,000,000 United States dollar | superseded | [clm_3D88466BC04E](/claim/clm_3D88466BC04E.md) - 2024-09-30 to 2024-12-31 | money | total_assets | 137,695,000,000 United States dollar | superseded | [clm_B966FE925B65](/claim/clm_B966FE925B65.md) - 2024-09-30 to 2024-12-31 | money | total_equity | -23,552,000,000 United States dollar | superseded | [clm_2300643BF1C7](/claim/clm_2300643BF1C7.md) - 2024-10-16 to 2025-01-27 | money | shares_outstanding | 618,200,911 shares | superseded | [clm_ED8C5E287612](/claim/clm_ED8C5E287612.md) - 2024-12-31 to 2025-03-31 | money | cash_and_equivalents | 13,801,000,000 United States dollar | superseded | [clm_39188FF6975D](/claim/clm_39188FF6975D.md) - 2024-12-31 to 2025-12-31 | money | net_income | -11,817,000,000 United States dollar | superseded | [clm_8951CA13065D](/claim/clm_8951CA13065D.md) - 2024-12-31 to 2025-12-31 | money | operating_income | -10,707,000,000 United States dollar | superseded | [clm_22E2E0AE0C49](/claim/clm_22E2E0AE0C49.md) - 2024-12-31 to 2025-12-31 | money | research_and_development | 3,812,000,000 United States dollar | superseded | [clm_C60C42BF2CBA](/claim/clm_C60C42BF2CBA.md) - 2024-12-31 to 2025-12-31 | money | revenue | 66,517,000,000 United States dollar | superseded | [clm_606F3DA24560](/claim/clm_606F3DA24560.md) - 2024-12-31 to 2025-03-31 | money | total_assets | 156,363,000,000 United States dollar | superseded | [clm_DD412EC5BE93](/claim/clm_DD412EC5BE93.md) - 2024-12-31 to 2025-03-31 | money | total_equity | -3,908,000,000 United States dollar | superseded | [clm_0C87CB0B317F](/claim/clm_0C87CB0B317F.md) ## 2025 - 2025-01-27 to 2025-04-16 | money | shares_outstanding | 750,074,411 shares | superseded | [clm_0F07A71EDEE9](/claim/clm_0F07A71EDEE9.md) - 2025-03-31 to 2025-06-30 | money | cash_and_equivalents | 10,142,000,000 United States dollar | superseded | [clm_BAB564BF95BB](/claim/clm_BAB564BF95BB.md) - 2025-03-31 to 2025-06-30 | money | quarterly_net_income | -37,000,000 United States dollar | superseded | [clm_29F13DB5463A](/claim/clm_29F13DB5463A.md) - 2025-03-31 to 2025-06-30 | money | quarterly_operating_income | 461,000,000 United States dollar | superseded | [clm_765F4E95240B](/claim/clm_765F4E95240B.md) - 2025-03-31 to 2025-06-30 | money | quarterly_research_and_development | 844,000,000 United States dollar | superseded | [clm_1344DAC277F5](/claim/clm_1344DAC277F5.md) - 2025-03-31 to 2025-06-30 | money | quarterly_revenue | 19,496,000,000 United States dollar | superseded | [clm_7D60F42E7BBA](/claim/clm_7D60F42E7BBA.md) - 2025-03-31 to 2025-06-30 | money | total_assets | 156,494,000,000 United States dollar | superseded | [clm_166A5E9FAAD5](/claim/clm_166A5E9FAAD5.md) - 2025-03-31 to 2025-06-30 | money | total_equity | -3,325,000,000 United States dollar | superseded | [clm_B97C7519D927](/claim/clm_B97C7519D927.md) - 2025-04-16 to 2025-07-22 | money | shares_outstanding | 754,005,474 shares | superseded | [clm_13D6DDB87F30](/claim/clm_13D6DDB87F30.md) - 2025-06-30 to 2025-09-30 | money | cash_and_equivalents | 7,087,000,000 United States dollar | superseded | [clm_422245D16807](/claim/clm_422245D16807.md) - 2025-06-30 to 2025-09-30 | money | quarterly_net_income | -611,000,000 United States dollar | superseded | [clm_E68BCD42CF58](/claim/clm_E68BCD42CF58.md) - 2025-06-30 to 2025-09-30 | money | quarterly_operating_income | -176,000,000 United States dollar | superseded | [clm_5DCD8BCDA64C](/claim/clm_5DCD8BCDA64C.md) - 2025-06-30 to 2025-09-30 | money | quarterly_research_and_development | 910,000,000 United States dollar | superseded | [clm_7B6F0695FDEC](/claim/clm_7B6F0695FDEC.md) - 2025-06-30 to 2025-09-30 | money | quarterly_revenue | 22,749,000,000 United States dollar | superseded | [clm_EBC7850469A0](/claim/clm_EBC7850469A0.md) - 2025-06-30 to 2025-09-30 | money | total_assets | 155,120,000,000 United States dollar | superseded | [clm_7FEB1A4F14C9](/claim/clm_7FEB1A4F14C9.md) - 2025-06-30 to 2025-09-30 | money | total_equity | -3,295,000,000 United States dollar | superseded | [clm_DD87EA01C011](/claim/clm_DD87EA01C011.md) - 2025-07-22 to 2025-10-22 | money | shares_outstanding | 756,157,695 shares | superseded | [clm_4AEDD092142C](/claim/clm_4AEDD092142C.md) - 2025-09-30 to 2025-12-31 | money | cash_and_equivalents | 6,173,000,000 United States dollar | superseded | [clm_B46F3340DD91](/claim/clm_B46F3340DD91.md) - 2025-09-30 to 2026-03-31 | money | quarterly_net_income | -5,337,000,000 United States dollar | superseded | [clm_044E8765AC2B](/claim/clm_044E8765AC2B.md) - 2025-09-30 to 2026-03-31 | money | quarterly_operating_income | -4,781,000,000 United States dollar | superseded | [clm_98E8E9771B8B](/claim/clm_98E8E9771B8B.md) - 2025-09-30 to 2026-03-31 | money | quarterly_research_and_development | 897,000,000 United States dollar | superseded | [clm_60EB7C7FBFB8](/claim/clm_60EB7C7FBFB8.md) - 2025-09-30 to 2026-03-31 | money | quarterly_revenue | 23,270,000,000 United States dollar | superseded | [clm_C3CB6241B02A](/claim/clm_C3CB6241B02A.md) - 2025-09-30 to 2025-12-31 | money | total_assets | 150,023,000,000 United States dollar | superseded | [clm_C5ADFD6FCE6C](/claim/clm_C5ADFD6FCE6C.md) - 2025-09-30 to 2025-12-31 | money | total_equity | -8,250,000,000 United States dollar | superseded | [clm_C42F83E34E0C](/claim/clm_C42F83E34E0C.md) - 2025-10-22 to 2026-01-23 | money | shares_outstanding | 760,095,468 shares | superseded | [clm_F66860EA1A89](/claim/clm_F66860EA1A89.md) - 2025-12-31 to 2026-03-31 | money | cash_and_equivalents | 10,921,000,000 United States dollar | superseded | [clm_4B994E8D6B61](/claim/clm_4B994E8D6B61.md) - 2025-12-31 | money | net_income | 2,235,000,000 United States dollar | valid | [clm_6717D6429433](/claim/clm_6717D6429433.md) - 2025-12-31 | money | operating_income | 4,281,000,000 United States dollar | valid | [clm_62BB75F887DC](/claim/clm_62BB75F887DC.md) - 2025-12-31 | money | research_and_development | 3,615,000,000 United States dollar | valid | [clm_E2360D77964A](/claim/clm_E2360D77964A.md) - 2025-12-31 | money | revenue | 89,463,000,000 United States dollar | valid | [clm_5F8DA6FAA840](/claim/clm_5F8DA6FAA840.md) - 2025-12-31 to 2026-03-31 | money | total_assets | 168,235,000,000 United States dollar | superseded | [clm_DA402E9F29EA](/claim/clm_DA402E9F29EA.md) - 2025-12-31 to 2026-03-31 | money | total_equity | 5,454,000,000 United States dollar | superseded | [clm_93A51636AEAB](/claim/clm_93A51636AEAB.md) ## 2026 - 2026-01-23 to 2026-04-15 | money | shares_outstanding | 785,347,096 shares | superseded | [clm_A512198B0333](/claim/clm_A512198B0333.md) - 2026-03-31 to 2026-06-30 | money | cash_and_equivalents | 9,441,000,000 United States dollar | superseded | [clm_F09187AB7AD0](/claim/clm_F09187AB7AD0.md) - 2026-03-31 to 2026-06-30 | money | quarterly_net_income | -4,000,000 United States dollar | superseded | [clm_3FAE28AFA508](/claim/clm_3FAE28AFA508.md) - 2026-03-31 to 2026-06-30 | money | quarterly_operating_income | 448,000,000 United States dollar | superseded | [clm_E61765C18A38](/claim/clm_E61765C18A38.md) - 2026-03-31 to 2026-06-30 | money | quarterly_research_and_development | 903,000,000 United States dollar | superseded | [clm_86E6584CF02A](/claim/clm_86E6584CF02A.md) - 2026-03-31 to 2026-06-30 | money | quarterly_revenue | 22,217,000,000 United States dollar | superseded | [clm_537F93E1CCF2](/claim/clm_537F93E1CCF2.md) - 2026-03-31 to 2026-06-30 | money | total_assets | 164,787,000,000 United States dollar | superseded | [clm_F12582DF2830](/claim/clm_F12582DF2830.md) - 2026-03-31 to 2026-06-30 | money | total_equity | 5,987,000,000 United States dollar | superseded | [clm_3A349C585A45](/claim/clm_3A349C585A45.md) - 2026-04-15 to 2026-07-21 | money | shares_outstanding | 788,302,331 shares | superseded | [clm_1935286C702B](/claim/clm_1935286C702B.md) - 2026-06-30 to 2026-09-30 | money | cash_and_equivalents | 7,239,000,000 United States dollar | superseded | [clm_9C3D9DB4A847](/claim/clm_9C3D9DB4A847.md) - 2026-06-30 to 2026-09-30 | money | quarterly_net_income | -444,000,000 United States dollar | superseded | [clm_ECCEA3E93E99](/claim/clm_ECCEA3E93E99.md) - 2026-06-30 to 2026-09-30 | money | quarterly_operating_income | 156,000,000 United States dollar | superseded | [clm_C3FC1D35FE5E](/claim/clm_C3FC1D35FE5E.md) - 2026-06-30 to 2026-09-30 | money | quarterly_research_and_development | 921,000,000 United States dollar | superseded | [clm_99C9CEA2608A](/claim/clm_99C9CEA2608A.md) - 2026-06-30 to 2026-09-30 | money | quarterly_revenue | 24,560,000,000 United States dollar | superseded | [clm_A378E554E475](/claim/clm_A378E554E475.md) - 2026-06-30 to 2026-09-30 | money | total_assets | 165,870,000,000 United States dollar | superseded | [clm_C912523569A4](/claim/clm_C912523569A4.md) - 2026-06-30 to 2026-09-30 | money | total_equity | 6,100,000,000 United States dollar | superseded | [clm_66EEA0BC9929](/claim/clm_66EEA0BC9929.md) - 2026-07-21 to 2026-10-20 | money | shares_outstanding | 790,370,020 shares | superseded | [clm_9FFC814936B5](/claim/clm_9FFC814936B5.md) - 2026-09-30 | money | cash_and_equivalents | 9,498,000,000 United States dollar | valid | [clm_37129FF5C63D](/claim/clm_37129FF5C63D.md) - 2026-09-30 | money | quarterly_net_income | -116,000,000 United States dollar | valid | [clm_D19898A2D891](/claim/clm_D19898A2D891.md) - 2026-09-30 | money | quarterly_operating_income | 354,000,000 United States dollar | valid | [clm_6BE556540AFB](/claim/clm_6BE556540AFB.md) - 2026-09-30 | money | quarterly_research_and_development | 830,000,000 United States dollar | valid | [clm_1A7701B6C822](/claim/clm_1A7701B6C822.md) - 2026-09-30 | money | quarterly_revenue | 24,188,000,000 United States dollar | valid | [clm_178152B46421](/claim/clm_178152B46421.md) - 2026-09-30 | money | total_assets | 170,739,000,000 United States dollar | valid | [clm_73248C4FB1A4](/claim/clm_73248C4FB1A4.md) - 2026-09-30 | money | total_equity | 6,547,000,000 United States dollar | valid | [clm_6AD4B55E9729](/claim/clm_6AD4B55E9729.md) - 2026-10-20 | money | shares_outstanding | 792,449,940 shares | valid | [clm_35BFE9CE9589](/claim/clm_35BFE9CE9589.md) ## undated - undated | other | cik | 0000012927 | valid | [clm_69652F124599](/claim/clm_69652F124599.md) - undated | other | fiscal_year_end | 12-31 | valid | [clm_3BD2175D8881](/claim/clm_3BD2175D8881.md) - undated | other | headquarters | Arlington | valid | [clm_1ABB46646719](/claim/clm_1ABB46646719.md) - undated | other | listed_on | NYSE | valid | [clm_4B0DC0FEB234](/claim/clm_4B0DC0FEB234.md) - undated | other | registrant_name | BOEING CO | valid | [clm_4EAC0457D877](/claim/clm_4EAC0457D877.md) - undated | other | sic_industry | Aircraft (3721) | valid | [clm_67A2463D89D5](/claim/clm_67A2463D89D5.md) - undated | other | state_of_incorporation | DE | valid | [clm_805923DEA632](/claim/clm_805923DEA632.md) - undated | other | ticker | BA | valid | [clm_00B307ED1E4A](/claim/clm_00B307ED1E4A.md) - undated | other | ticker | BA-PA | valid | [clm_2873742388F4](/claim/clm_2873742388F4.md) - undated | other | website | https://boeing.com/ | unverified | [clm_E4487CA53F10](/claim/clm_E4487CA53F10.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.